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THE ROLE OF CBL FAMILY OF E3 UBIQUITIN LIGASES IN 
INTESTINAL EPITHELIAL HOMEOSTASIS 
Neha Zutshi, Ph.D. 
 
Supervisor: Hamid Band, M.D., Ph.D 
All adult organs are endowed with a small pool of resident stem cells that must be 
maintained throughout life to provide for cell turnover during homeostasis and tissue 
repair following any injury. The unique ability to self-renew as well as to differentiate into 
functional cells of organs in which they reside makes stem cells essential for the 
maintenance of organ systems. It is now becoming increasingly evident that aberrant 
activity of stem cells contributes to diseases such as cancer or tissue/organ atrophy. 
Thus, it is critical to better understand the mechanisms that regulate adult stem cells. 
Ligand-activated receptor tyrosine kinases (RTKs) represent an important means to 
regulate adult stem cells. We and others have established the CBL-family ubiquitin 
ligases as key negative regulators of RTKs. However, physiological roles of CBL 
proteins in intestinal epithelial homeostasis are unknown. Recently, we have shown that 
CBL and CBL-B function as redundant but essential regulators of hematopoietic stem 
cell (HSC) quiescence and their combined deletion in HSCs of mice leads to a rapidly-
fatal myeloproliferative disorder, mimicking a similar leukemic disease associated with 
mutations of CBL in humans. CBL and CBL-B have also been shown to help maintain 
asymmetric neural stem cell division. Any role of CBL proteins in the regulation of 
epithelial stem cells has not been reported. To address such a role, we generated a 
novel mouse model (Cbl-flox/flox; Cbl-b-null; Lgr5-EGFP-IRES-CreERT2; Rosa26-LacZ) 
to confer concurrent tamoxifen-inducible loss of CBL and CBL-B in the Lgr5-expressing 
intestinal epithelial stem cells (IESCs). Tamoxifen injection in this inducible CBL/CBL-B 
  
 
iii 
double knockout (iDKO) mouse model resulted in a rapid and significant reduction in the 
Lgr5-High IESC pool with a concomitant increase in the Lgr5-Lo transit amplifying cells. 
Lineage tracing using LacZ-staining revealed an increase in the number of blue progeny 
in the iDKOs, suggesting an increased IESC commitment to differentiation. Of the 
progeny, iDKO animals showed a propensity towards enterocyte and goblet cell fate at 
the expense of Paneth cells. Loss of IESCs in iDKO mice led to slower recovery from 
intestinal epithelial injury due to X-ray radiation of the abdomen. In vitro deletion of CBL 
proteins in the crypt culture recapitulated the loss of self renewal phenotype and was 
associated with hyperactivation of MAPK pathway and downregulation of Wnt pathway 
effector TCF4. These results demonstrate a novel requirement of CBL/CBL-B in the 
maintenance of a well-studied epithelial stem cell compartment, the IESC, and suggest 
that CBL proteins by regulating MAPK pathway protect IESCs from exhaustion.  
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1 Introduction 
1.1 Development and architecture of the small intestine 
Gastrointestinal (GI) tract development doesn’t begin until gastrulation is complete and 
the three germ layers come together in the form of hollow tube in which the innermost 
endoderm (which later becomes mucosal epithelium) gets surrounded by mesoderm 
(derivatives of which become loose connective tissue, vascular structure and 
muscularis) and ectoderm (that forms  enteric nervous system) that then undergo 
complex patterning along the three axes of symmetry of the embryo (anterior-posterior, 
dorsal-ventral, left-right) (1, 2). While the anterior-posterior axis divides the GI tract into 
foregut (forming pharynx, esophagus, and stomach), midgut (small intestine, cecum and 
ascending colon) and hindgut (fated to become rest of the colon, rectum and anus), the 
dorso-ventral and left-right axes guide counterclockwise turning and looping of the gut 
keeping the stomach on the left (2, 3). The innermost endoderm layer of the tube retains 
its stratified structure until mid-late gestation (E15 in mice) when it begins to undergo 
cytodifferentiation into to columnar epithelial cells upon receiving inductive signals from 
the surrounding mesoderm (1, 4). These signals also enable the endoderm derived 
epithelium to model into luminal projections called “villi” and proliferative “intervillus” 
epithelium. This process is complete by E19 in mice (figure1.1). Crypts begin to 
organize from intervillus epithelium between postnatal day 1 (P1) to postnatal day 14 
(P14). Epithelial cell proliferation in the intestine rapidly increases as crypts multiply in 
number by a process called crypt fission and villi lengthen as rate of proliferation 
exceeds the rate of cell death. Development of murine gut is complete by P28 (1).  
The adult GI tract comprises of four layers (figure1.2). The luminal-most layer is 
called mucosa. It comprises of the columnar epithelium and supporting loose connective 
tissue called lamina propria that sit on top of a smooth muscle layer called “muscularis 
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mucosae”. Mucosal layer rests on top of the submucosa which is made up of connective 
tissue rich in blood and lymph vessels, nerve fibers, and cells of the immune system. 
Submucosa is placed on top of muscularis propria that is made up of inner circular 
smooth muscle fibers and outer longitudinal smooth muscle layer. In between these two 
layers of muscularis propria are autonomic nerve fibers and ganglionic clusters of the 
myenteric plexus. This enables neural control of the peristaltic movement initiated in the 
muscularis propria that allows passage of the food along the gut. Outermost layer of the 
intestine is called serosa which is a mesothelium lining that protects the gut from 
frictional damage in the peritoneum (5). 
1.2 The Intestinal Epithelium 
The major functions of the intestine include digestion and absorption of nutrients 
entering the gut lumen and forming a barrier against pathogens. These functions are 
carried out by the specialized columnar epithelial cells of the mucosal layer of the 
intestine. The intestinal epithelium is organized into luminal finger-like protrusions called 
“villi” (to increase the surface area for absorption) and invaginations into the underlying 
submucosa called the “Crypts of Lieberkühn”. The epithelial lining of the intestine is a 
unique tissue that undergoes rapid turnover most likely propelled due to exposure to 
constant mechanical, chemical and biological insults. The entire lining is replaced every 
3-5 days in mammals. To balance the loss of cells, intestinal epithelial stem cells 
(IESCs) and their transit amplifying progeny residing within the crypt carry out extensive 
proliferation (6, 7). While the IESCs divide every 24 hours to form the transit amplifying 
compartment, the latter divides every 12 hours for 4 cell divisions until it terminally 
differentiate into cells of absorptive or secretory lineage that move on to the villi 
connected to the crypt (8).  
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Figure 1-1 Development of the gastrointestinal tract. 
Formation of the endoderm as a part of gastrulation occurs first around E5-E7.5 
in mice. The hollow endodermal gut tube forms when two ventral invaginations, 
one at the anterior (anterior intestinal portal, AIP) and the other at the posterior 
(caudal intestinal portal, CIP) end of the embryo elongate and fuse together. At 
this time lateral plate-derived splanchnic mesoderm comes to surrounds the 
endoderm and connects the tube to the dorsal body wall.  At a later time point 
neural crest cells from the dorsal neural tube migrate and colonize the gut to 
establish the (ENS). The endoderm at E10.5 is a stratified epithelium that 
undergoes morphogenesis into columnar epithelium that moulds into luminal 
projections called villi separated by intervillus proliferative zones by E15.  
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Noah et al., Experimental Cell Research 317 (2011) 2702-2710. 
Figure 1.1 
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Figure 1-2 Architecture of mammalian intestine. 
The schematic shows the organization of different layers of the intestine 
namely outhermost Serosa, followed by Muscularis which encircles 
Submucosa and the innermost layer of Mucosa. 
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Wallace et al., Mechanisms of Development 122 (2005) 157–173. 
Figure 1.2 
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The differentiated cells further migrate along the villus for the next 2-3 days post 
which they undergo cell death and fall off into the intestinal lumen. These differentiated 
functional cells are well defined by their morphology, location, function and marker 
expression (figure 1.3). These include the enterocytes, goblet cells, Paneth cells, 
enteroendocrine cells, tuft cells and M cells. The absorptive enterocytes are the most 
abundant progeny lining the GI tract. They are columnar with brush border epithelium on 
their apical surface. These cells are also a storehouse of various hydrolytic enzymes 
which they secrete into the lumen to allow breakdown of partially digested chyme. These 
enzymes such as sucrase isomaltase, lactase and alkaline phosphatase also help 
identify enterocytes in the gut. Goblet cells produce and secrete mucous to lubricate and 
protect the epithelial lining. The mucous layer in the small intestine can be divided into 
two: a firm, sterile inner layer and a more pervious outer layer that harbors IgAs and anti-
mircrobial peptides to block the pathogens. Goblet cells increase in number from 
proximal to distal end of the intestine. They are mostly present on the villus but can be 
found in the crypts as well. They can be recognized by their “goblet shape”, by staining 
the tissues with Periodic acid-Schiff (PAS) stain that labels mucopolysaccharides and by 
expression of proteins such as Mucin2.  Paneth cells are the only post-mitotic cells 
present at the crypt base intercalated between CBC intestinal stem cells. They thus 
serve niche signals to the stem cells. Paneth cells also secrete antimicrobial compounds 
such as defensins and lysozyme into the gut lumen. They are also unique as they are 
the only differentiated cell type that lives for as long as 6-8 weeks. They can be 
recognized by their characteristic eosinophilic granules, staining with PAS and 
expression of Lysozyme. Neuroendocrine hormone secreting enteroendocrine cells and 
opioid secreting tuft cells are rare populations of epithelial cells that can be present on 
the villi or the crypt. They are recognized by markers such as ChromograninA and 
DCaMKL1 respectively. Lastly, Microfold or M cells present on lymphoid Peyer’s patches 
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present antigens from the gut lumen to the underlying immune cells. Glycoprotein 2 is a 
marker for mature M cells (6, 7, 9). 
Because of the clearly defined hierarchy of cells, well-understood architecture of the 
tissue and ease of in vitro manipulation due to established markers and protocols, the 
intestinal epithelium serves as an attractive model system to study proliferation, self-
renewal, differentiation, apoptosis and migration. 
1.3 Intestinal Epithelial Stem Cell  
Stem cells are present in most adult tissues and are defined as the cells that can 
maintain tissue homeostasis by harboring the capacity to generate all mature cell types 
of a given organ, as well as renew their own pool. They were also proposed to be rare, 
quiescent and dividing asymmetrically to maintain one of their own while creating one 
progenitor to differentiate further. After a long-standing debate about the identity of stem 
cells, it has now been established that the true stem cells of the intestinal epithelium are 
the crypt base columnar cells (CBCs) present at the base of the crypt intermingled with 
Paneth cells. CBCs were first identified by Cheng and Leblond in 1974 (10-12). Using 
electron microscopy, they identified that crypt base was not just made of differentiated 
Paneth cells but also comprised of slender, wedge shaped CBCs (figure 1.4). They also 
provided evidence for “stemness” of this population by employing a crude method of 
lineage trace, where they analyzed radiolabeled phagosomes in CBCs that had survived 
the exposure to 3H-Thymidine and phagocytosed other CBCs that did not. They showed 
that the radioactivity could later on be located in more mature cells. 
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Figure 1-3 Organization of cells along the crypt-villus axis. 
The schematic shows stem and transit-amplifying (TA) compartment of the 
intestine within the crypt and arrangement of more differentiated cells along 
the villus. 
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Modified from Schuijers and Clevers. The EMBO Journal 31 (2012), 2685–2696 
Figure 1.3 
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Figure 1-4 Electron micrograph of a small intestine crypt base. 
It shows CBC stem cells (black arrows) identified by their slender shape, basal 
nuclei and luminal microvilli, tightly intermingled with Paneth cells (red arrows). 
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Nick Barker et al., Cell Stem Cell 11(2012) 452-460. 
Figure 1.4 
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Recently, the cause of CBCs as a stem cell candidate was championed by Clevers 
group (13). They identified a Wnt target gene, Lgr5 that was exclusively expressed in the 
CBCs. They used Lgr5 promoter driven tamoxifen inducible-Cre recombinase fusion 
protein, Cre-ERT2 and transgenic Cre reporter allele R26-Lox-Stop-Lox-LacZ 
expression to unambiguously establish CBCs as multipotent, long-lived stem cells of the 
intestine (13). It was, however, not easy to establish Lgr5+ CBCs as true stem cells of 
the intestine because they challenged the accepted paradigm for stemness. They were 
neither rare (14-15 per crypt) nor quiescent (divided every 24 hours) (13, 14, 15). They 
were relatively resistant to radiation injury and divided symmetrically (13, 14). Since 
then, however, Lgr5+ cells have been identified as having self-renewal potential in 
several epithelial organs such as hair follicle (16), mammary gland (17, 18), stomach 
(19), kidney (20), inner ear (21), pancreas (22)(23) and liver (23). 
Another population of stem cells called +4 stem cells fitted the traditional definition of 
stemness and was originally proposed as the label retaining putative stem cell of the 
intestine by Potten and colleagues (24, 25). Since then several groups have reported the 
presence of a rare, quiescent stem cell  around the +4 position relative to the base of the 
crypt identified by expression of various markers such as Bmi1(26, 27, 29), Lrig1 (30), 
HopX (31), mTert (32), pPTEN (33, 34), and so on. Although most of these studies have 
relied on the rarity, quiescent nature (DNA label retention) and the ability to regenerate 
epithelium upon injury, only a handful of them have used the gold-standard of lineage 
tracing to establish the multipotency of these candidates (27, 30, 31). Nonetheless, the 
quiescent nature and low abundance of these stem cells in the gut can’t justify these 
cells as the sole bona fide stem cells that could meet the homeostatic needs of the 
organ. Indeed, several studies have now established that CBCs are the actual work-
horses that meet the daily requirements of proliferation and differentiation while 
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quiescent +4 cells are the reserve stem cell population called in during the times of 
stress(13, 26, 30).  
More recently this reconciliation and agreement about the separate roles of Lgr5+ 
and +4 stem cells has been put to further test. It was shown that the expression of all the 
+4 stem cell markers was highly enriched in the Lgr5+ stem cells (32). Plus, when the 
entire Lgr5 expressing population was wiped out using Lgr5-DTR mice (a model in which 
human diphtheria toxin receptor was knocked-into the Lgr5 locus to selectively ablate 
Lgr5+ cells following exposure to Diphtheria toxin)  mice could not recover from radiation 
induced epithelial injury (35). These experiments hinted that quiescent stem cells were 
not a separate compartment but a sub-population of Lgr5+ CBCs. Takeda et al., in a 
landmark paper showed a bi-directional interconversion between these two populations 
of stem cells (31).  
A further twist in the tale came about when Buczaki et al., showed that Lgr5 
expressing label retaining cells (expressing all the +4 stem cell markers) are actually 
secretory progenitors (36). These cells under normal homeostasis are destined to 
become Paneth and other secretory cells but under radiation injury conditions can be re-
wired to become stem cells that then contribute to regeneration.  Similarly another study 
identified that DLL1 expressing secretory progenitor regained stemness under conditions 
of in vivo stress or in vitro culture (37). In the same vein, Stamataki et al., in 2011, 
showed that strong expression of DLL1 and exit from cell cycle were linked together in 
the intestinal crypts (38). More recently, the Clevers group has shown that enterocyte 
progenitors could also contribute to epithelial homeostasis in the absence of Lgr5+ stem 
cells (39). Thus, keeping these multiple studies of plasticity within the crypt cells in mind, 
at present it seems that stemness may not be hard-wired in the intestinal crypt cells and 
may be a function of exposure to the right cues from the niche (40).   
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1.4 Lgr5+ Stem Cells 
During development, Lgr5+ cells are first observed at P1 as cluster of cells in the 
intervillus epithelium. P5 onwards as crypts begin to form, they settle down to the bottom 
of the crypt and it is after P15 that they start to mingle with the Paneth cells. Lineage 
tracing as early P5 has established that Lgr5+ cells possess stem cell characteristics 
(42). Paneth cells and surrounding mesenchymal tissue form a niche that tightly 
regulates the strength of signals needed to maintain these stem cells in a narrow zone of 
the crypt base. A number of studies have investigated the role the Paneth cells as 
providers of niche signals to the CBCs (42-47). While some have suggested that Paneth 
cells are dispensable for maintenance of stem cells (42, 44) possibly due to the 
overlapping signals by the sub-epithelial myofibroblasts (43, 48), others have shown that 
loss of Paneth cells results in loss of stem cell compartment (45-47). Also co-culture of 
stem cells with Paneth cells significantly increases the survival of stem cells in vitro. 
Among the several factors secreted by Paneth cells, Wnt3a, TGF-α/EGF and Jag1/DLL4 
seem to be the most potent at providing stemness cues to the CBCs (49). These factors 
have thus been used extensively now to culture Lgr5+stem cell and their progeny as 3 
dimensional organoids. 
Functionally, Lgr5 is a seven pass transmembrane protein that is a receptor for the 
Rspondin family of ligands (RSPO1-4) and potentiates Wnt/β-catenin signaling (50-53). 
Mechanistic dissection of this agonistic function of Lgr5 in the Wnt pathway was made 
possible after the discovery of RNF43 and ZNRF3, the E3 Ubiquitin ligases that 
downregulate Frizzled receptors by ubiquitinating and targeting the receptors for 
lysosomal degradation (52, 53). Lgr5-bound to RSPO1 was shown to engage RNF43 
and ZNRF4 in a complex that was eventually cleared from the membrane and allowed 
stabilization of Wnt signaling complex at the plasma membrane (53).  Whole body 
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knockout of Lg5 leads to neonatal lethality possibly due to swallowing air because of 
ankyloglossia (defects in tongue and jaw) resulting in gastrointestinal distention and no 
milk in the stomach of these pups (54). Lgr stands for leucine-rich repeat containing G-
protein-coupled receptor. Lgr5 has two other homologues, Lgr4 and Lgr6. The three 
members harbor multiple leucine rich repeats (16-18) in their extracellular domain 
flanked by cysteine-rich sequences on both sides of these repeats, followed by a 7 
transmembrane region and a cytoplasmic tail that unlike other GPCRs does not interact 
with heterotrimeric G proteins or β-arrestin (50, 55, 56) (figure1.5). Thus, their ability to 
modulate Wnt pathway is independent of GPCR function (50, 55). While Lgr5 expression 
in the intestine is restricted to CBCs, its homologue Lgr4 is expressed throughout the 
crypt (55). Lgr4 knockouts/ hypomorphs were shown to have multiple developmental 
defects including neonatal lethality, growth retardation, reproductive and ophthalmic 
deficits depending upon the background strain of mice or the extent of loss of Lgr4 (57). 
It is interesting to note that while conditional deletion of Lgr5 in the adult intestinal 
epithelium did not affect normal homeostasis, loss of Lgr4 caused a marked reduction in 
proliferation within the crypts and combined loss of both the family members was fatal 
within 4 to 5 days of induction of deletion (55).  Lgr6 is not expressed in the gut and is 
mostly thought not be involved in canonical Wnt signaling, however, Lgr6+ stem cells 
have been found in the isthmus region of the hair follicle (15). Lgr6 Knockout mice have 
no obvious phenotype (15). 
In an effort to better understand how mutation carrying crypts out grow normal 
crypts, scientists have studied the kinetics of self-renewal of Lgr5+ cells, because in 
addition to maintaining normal intestinal epithelium, these cells have also been 
implicated to be the cells-of-origin of mutation in colon cancer (58). Multi-color lineage 
tracing was carried out by Snippert et al., using R26-Confetti mice crossed to Lgr5-
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CreERT2 to follow the clonal behavior of individual Lgr5+ cell in multiple crypts at the 
same time (14). It was found that all the Lgr5+ cells labeled within the first 24 hours of 
tamoxifen induction and divided symmetrically to yield equally potent stem cells but over 
time any one clone stochastically predominated evicting others from the crypt base in a 
neutral competition for niche and thereby driving a crypt to monoclonality (14). This 
neutral kinetics and symmetrical cell division by Lgr5+ cells was independently 
demonstrated by Winton and colleagues as well (59) and has now also been accepted to 
occur in humans (60-63). Ritsma et al. looked further at how the niche signals dictated 
the spatiotemporal assignment of the winner stem cell clone during the neutral drift 
phenomenon using in vivo live imaging of lineage tracing through abdominal imaging 
window implanted in mice (64). They showed that most often the central CBCs would 
“win” by out-competing the rest of them creating a monoclonal crypt. This was observed 
to be due to passive displacement of the border stem cells out of the niche following 
division of the central stem cells to allow positioning and better adjustment of the newly 
formed stem cells within the limited niche space even though all the stem cells were 
equipotent to begin with, thus, forcing the evicted stem cells to undergo differentiation 
(64).  
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Figure 1-5 Predicted structure of Lgr5. 
The schematic shows the domain structure of Lgr5 comprising of an 
extracellular domain with multiple leucine-rich repeats, a 7 pass trans-
membrane domain, followed by an intracellular domain. 
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Barker and Clevers. Gastroenterology 138 (2010) 1681-1696. 
Figure 1.5 
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Because of their cycling nature, Lgr5+ cells are considered to be more susceptible to 
mucosal insults such as irradiation and cytotoxic drugs like doxorubicin and 5-FU. It has 
been shown that under these conditions, quiescent/ label retaining stem/progenitor 
population can take over homeostasis. In a mouse model carrying, Lgr5-DTR, Bmi1-
CreERT2 and Rosa26-LacZ alleles it was shown that diphtheria toxin exposure did not 
affect the normal epithelial integrity of the intestine while the same treatment along with 
tamoxifen (to activate Bmi1 Cre) increased LacZ+ lineage tracing ribbon of cells from the 
Bmi1 locus. These findings were confirmed independently by another group (26). 
Lineage tracings from HopX and Lrig1 loci were found to increase as well upon exposure 
to radiation (30, 31). More recently, secretory progenitors marked by DLL1 and LRC 
have also been shown to contribute to epithelial homeostasis when subjected to 
mucosal injury (36, 37). It has been proposed that these more mature cells, upon falling 
back into the “stem cell zone” can regain stemness and de-differentiate. What is also 
interesting is that for these progenitors to form organoids in vitro, Wnt3a is necessary (a 
true niche signal provided by Paneth and other non-epithelial cells). The LRC reported in 
the literature is relatively short-lived (up to 4 weeks after labeling) and may not be a true 
stem cell. However, new LRCs keep forming from the Lgr5 compartment on a regular 
basis that can be called into action in case of damage to the cycling stem cell 
compartment (66). These multiple studies demonstrating exquisite plasticity of several 
crypt progenitor/ LRCs could be indicative of the fact that stemness is not a function of 
expression of a particular marker in the intestinal epithelium but is defined by the 
positioning of a cell within the niche. Thus, it is critical to look at the key signaling 
networks in action within and surrounding the crypts. 
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1.5 Signaling pathways in the maintenance of intestinal 
epithelium  
The location of CBCs deep in the crypt pocket intermingled with Paneth cells puts them 
in an environment which is conducive for short range interactions as is required in case 
of pathways such as Wnt and Notch. Below is the description of different signaling 
pathways operational in the crypt milieu that maintain stem cell number and function. 
1.5.1 Wnt 
Wnt signaling regulates several aspects of maintenance of intestinal epithelial 
homeostasis. It is critical for keeping proliferation intact within the stem/transit amplifying 
compartment intact, inhibiting differentiation (other than Paneth cells), and regulating 
localization of cells along the crypt-villus axis.  
Wnts are the ligands that act within a short range to trigger this signaling cascade by 
binding to their cognate receptors Frizzled (Fzd) and co-receptors Lrp5/6 present on 
nearby cells via their palmitate group. This binding event introduces a conformational 
change in these receptors that allows associated kinase, CK1γ to phosphorylate the 
cytoplasmic tail of Lrp. This phosphorylated complex sequesters scaffold proteins 
Disheveled (Dsh) and Axin (which are a part of a complex including casein kinase1 
(CK1), adenomatous polyposis coli (Apc) and Glycogen synthase kinase 3β (GSK3β) 
that in the absence of Wnt activation binds to β-catenin to phosphorylate its amino-
terminus to target it for proteosomal degradation), to allow stabilization of β-catenin,  that 
then translocates to the nucleus and interacts with TCF/LEF family of transcription 
factors to induce transcription of Wnt-target genes (67).   
In the intestine, Wnt3, Wnt6 and Wnt9b are the main epithelial secreted Wnts, mostly 
by Paneth cells and Wnt2b, Wnt4, and Wnt5a are the mesenchymal Wnts (43). 
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Although, Fzd 2, 4, 5, 6 and 8 are all expressed in the epithelium, Fzd 7 is most 
abundantly expressed in the Lgr5+ CBCs along with LRP5 and 6 (68). It is also known 
that the mesenchyme surrounding the crypts secretes Wnt antagonists such as Frizzled 
related proteins 1 and 5 (the soluble proteins that compete for Wnts) and Dickkopfs 
(Dkks, inhibitors of LRP function) (69-71). The main effector of Wnt signaling in the adult 
small intestine, TCF4, is expressed all along the crypt-villus axis (69). 
The evidence for the vital role of Wnt pathway in intestinal epithelial self-renewal 
came from two major observations. One, along with the studies of loss of function 
mutations of Apc as a cause for familial adenomatous polyposis, several studies pointed 
to development of intestinal tumors with dysregulation of other Wnt pathway components 
(72-80). Two, abrogation of Wnt signaling through knockout of Tcf4 or overexpression of 
DKK1 resulted in complete loss of proliferation within the crypts (81-83).  
In association with other signaling pathways, Wnt also participates in fate 
determination of progenitors. Dysregulated Wnt signaling by the loss of Apc was shown 
to decrease differentiation towards all mature cell types except for Paneth cells and this 
phenotype was successfully rescued by c-Myc deletion (77, 78, 84). Similarly, 
overexpression of c-Myc caused loss of goblet cells (85). Paneth cells seem to depend 
extensively on the Wnt pathway for their maturation and positioning. Several Wnt-target 
genes regulate the function of Paneth cells such as cryptdins, defensin and Sox9 (47, 
78, 84, 86). Hyperactive Wnt doesn’t affect the number of Paneth cells but impacts their 
localization (84). On the other hand, disruption of β-catenin within a secretory progenitor 
compartment (marked by Neurogenin3) leads to reduced differentiation towards Paneth 
cells (87).  
Differentiation within the intestinal epithelium is closely connected to migration of 
cells out of the crypts and Wnt signaling regulates both migration and positioning of cells 
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along the crypt-villus axis. EphB receptors are receptor tyrosine kinases that regulate the 
migration of cells along the epithelial lining by remodeling the actin cytoskeleton (88-90).  
Interaction of EphB receptors with their transmembrane ligands (EphrinBs) generates 
repulsive forces that segregate cells expressing either of them into opposing gradients 
(88, 91). The Wnt pathway has been shown to positively regulate the expression of 
EphB receptors, Eph2 and Eph3, within the crypt while suppressing the expression of 
their ligands EphrinB1 and B2 which are highly expressed at the crypt-villus junction (92-
95).  Loss of EphB2 causes mislocalization of progenitor cells while loss of EphB3 
results mispositioning of Paneth cells along the crypt-villus axis (95, 92).     
1.5.2 Notch 
In the intestine, Notch signaling plays an important role in maintenance of stem cells as 
well as in the binary fate decision of secretory vs. absorptive cells (97-103).  
In mammals, the Notch family is comprised of 4 single transmembrane Notch 
receptors (Notch1–4) and 5 single transmembrane ligands, Delta-like1 (DLL1), Delta-like 
3 (DLL3), Delta-like 4 (DLL4), Jagged1 (Jag1) and Jagged 2 (Jag 2). Expression 
analysis of rodent gut has revealed that Notch 1 and Notch 2 are the main Notch 
receptors that are expressed in the gut (104). In situ hybridization, LacZ knock-in alleles 
for Dll1 and Dll4 and immunofluorescence staining has showed that Jag1, Dll1, and Dll4 
are the potential ligands for Notch receptors in the intestine (97, 104-106).  
The pathway initiates when ligand and receptor present on neighboring cells interact 
with each other leading to proteolytic cleavage and release of the intracellular domain 
(NICD) of the receptor.  NICD, upon release, translocates to the nucleus and forms a 
complex with the transcription factor CSL (RBP-J in mouse), inducing transcription of 
downstream target genes (107). Notch is able to regulate stem-cell proliferation and 
differentiation in the intestine through its target genes such as Ascl2, Olfm4 and Hes1 
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(101, 108).  Block in Notch pathway causes loss of expression of stem cell specific 
genes such as Olfm4, Ascl2 and Lgr5 and reduction in proliferating crypt progenitors 
(101, 103).  Notch regulates differentiation decisions through its target gene Hes1 which 
represses the expression of the basic helix-loop-helix transcription factor Atoh1 (also 
called Math1) (108). Atoh1 is the main regulator of secretory cell fate as its loss in the 
intestinal epithelium leads to complete absence of secretory cells. On the other hand, 
Hes-1 null mice have increased proportion of all the secretory cells at the cost of 
enterocytes (109, 110). Notch signaling also inhibits enteroendocrine fate specification 
by directly inhibiting the expression of Neurogenin3 (Ngn3). It is interesting to note that 
ectopic expression of Notch in the Ngn3+ enteroendocrine progenitor cells drives 
differentiation towards enterocytic and goblet cell fate (111, 112).  
The nature of interaction between Notch receptors and their ligands is that of lateral 
inhibition. Ligand expressing Paneth cells are located right next to the receptor 
expressing stem cells. This keeps the stem cells in an active Notch environment, 
maintaining proliferation and suppression of differentiation by downregulation of Atoh1 
and at the same time inhibits activation of Notch in its neighboring cells. In accordance 
with this thought, it has been observed that a transient increase in the expression of 
DLL1 within a cell overlaps with its exit from the cell cycle and these cells then become 
the “quiescent” secretory fate precursors (37, 38).   
Overall, genetic depletion of Notch pathway components (Notch1/Notch2) (41, 103) 
or DLL1/DLL4 (97) or pharmacological block through γ-secretase inhibitors (which 
prevent cleavage of NICD) (102) or receptor neutralizing antibodies (41, 101, 102) 
results in loss of proliferating cells and increased differentiation towards secretory cell 
fate. Thus, Notch signaling maintains proliferating crypt progenitors and balances 
between secretory and absorptive cell differentiation.  
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1.5.3 BMP 
In the context of intestine, BMP signaling is a potent inhibitor of proliferation and inducer 
of differentiation. This pathway includes the ligands, bone morphogenetic proteins 
(BMPs) that bind to a Ser/Thr receptor type I/II heterodimers to cause phosphorylation of 
the receptor type I and activation of downstream effectors of SMAD family of proteins 
which translocate to the nucleus to carry out transcription of BMP target genes. The 
receptors, ligands as well as the intracellular effectors are expressed in epithelium as 
well as in the surrounding stroma. Also, the soluble BMP inhibitors of the follistatin, 
chordin and gremlin family are expressed mostly within the mesenchyme (113). Studies 
have demonstrated that abrogating BMP signaling by knockout of Bmpr1A or 
overexpression of BMP inhibitor Noggin resulted in enhanced proliferation, increased 
crypt fission, ectopic formation of crypts along the crypt-villus axis and eventual 
development of intestinal polyposis (114, 115). Loss of BMP signaling results in impaired 
secretory cell differentiation and no effect on enterocytes (116). 
The anti-proliferative effect of BMP signaling has been attributed to its ability to 
antagonize Wnt signaling and partly by directly stabilizing p21CIP/WAF, the cell cycle 
inhibitor (117, 34). It is for this reason that the stroma around the crypt is enriched in 
BMP inhibitors gremlin and noggin (119).  
1.5.4 RTK/MAPK/PI3K Pathway 
Ample evidence supports an indispensable role of receptor tyrosine kinases (RTKs) and 
their ligands in intestinal development and maintenance, although the details of how the 
intracellular players further impact self-renewal, differentiation and migration are not as 
well documented as that for Wnt and Notch pathways.   
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Humans have 58 known RTKs that can be subdivided into 20 families. They all have 
similar domain architecture: an N-terminal extracellular ligand binding domain, a 
transmembrane region, followed by a C-terminal cytoplasmic tail that comprises of 
juxtamembrane regulatory regions and a tyrosine kinase domain. In an inactive state, 
these receptors can be found on the plasma membrane as sitting alone or in homo or 
hetero dimers with their family members. Ligand binding can induce dimerization of 
individual receptors or bring together already formed dimers into a conformation that 
allows activation of the tyrosine kinase domain in the C-terminus of these receptors. This 
activation leads to trans-phosphorylation of key tyrosine residues on these tails. These 
phospho-tyrosine residues then become signal transduction hubs through activation of 
downstream MAPK cascade or PI3K pathway. Receptor phosphorylation can also recruit 
Src homology-2 (SH2) or phosphotyrosine-binding domain (PTB) containing negative 
regulators of this signaling such as CBL or SHP1 that can instigate ubiquitination and 
targeting of the receptor for lysosomal degradation or dephosphorylation of signaling 
tyrosine residues respectively. This negative regulation is of extreme importance in 
keeping the signaling downstream of RTKs under check (120, 121). 
Specific roles for RTKs have been identified in the gut. It has been shown that, 
epidermal growth factor (EGF), the ligand for EGFR RTK, drives the mucosal maturation 
in utero, regulates expression of adult enterocytic enzymes (122-124), and promotes 
proliferation in neonatal and adult mammalian intestinal epithelium (125-127). Mice with 
compound deletion of EGFR ligands, TGF-α, EGF and amphiregulin (AR), show 
spontaneous duodenal lesions, stubbier villi, and increased susceptibility to Dextran 
sulfate-induced injury along with growth retardation (128). EGFR-dependent epithelial 
cell migration is required for epithelial renewal and wound healing (129-131). When 
mouse strain background permits live EGFR-/- births, pups display gross defects in the 
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intestinal mucosa along with reduced proliferation (132-134). The ISC niche function of 
Paneth cells requires them to secrete ErbB ligands (49). RTKs of the EphB-family, 
FGFR and IGFRs have also been shown to play crucial roles during gut morphogenesis, 
mucosal proliferation and crypt survival, differentiation and positioning of cells along the 
crypt-villus axis (88, 134-139). In addition, Lrig1, a negative regulator of ErbB family of 
RTKs was recently shown to be enriched within the crypt compartment and its loss led to 
formation of duodenal adenomas (30, 140). RTKs are also key players in oncogenesis 
and other pathologies of the gut (141-149). 
With respect to self-renewal and fate determination two sets of studies have 
elegantly demonstrated how RTKs can modulate the epithelial architecture. Heuberger 
et al., recently demonstrated that loss of Shp2, a positive regulator of RTK signaling, 
leads to expansion of Paneth cells at the cost of goblet cells along with an increase in 
the Lgr5+ stem cells. They attributed this phenotype to loss of Mek-Erk signaling, that 
potentiated Wnt signaling through de-stabilization of a shorter non-functional isoform of 
TCF4 (150). RTK signaling can also activate the PI3K/Akt pathway, which is a potent 
inducer of cell proliferation and inhibitor of apoptosis (151, 152). In the context of 
intestinal epithelium, PI3K/Akt pathway has been assessed through the impact of BMP 
signaling on PTEN, a negative regulator of the PI3K/Akt pathway (33, 34). It was shown 
that within the Label retaining +4 compartment, BMP signaling enhanced PTEN activity 
and inhibited nuclear accumulation of β-catenin (33, 34). Similarly, loss of PTEN resulted 
in de novo crypt formation and increased crypt fission and even intestinal polyp 
formation (33, 34, 154). This work showed how activated Akt, could induce 
phosphorylation of β-catenin and ultimately activation of Wnt (115, 34).  
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These divergent ways by which RTK signaling interacts with Wnt and other pathways 
makes it a unique signaling system that requires more detailed analysis especially of the 
context under which flux through these two different routes takes place.   
Through understanding of these different molecular networks that regulate stem cell 
function within its niche (figure1.6), scientists have developed in vitro culture conditions 
(including RSPO1, EGF, Noggin along with laminin based extracellular matrix)  to grow 
crypts as three dimensional organoids (figure1.7) (49). This ability to grow organoids in 
vitro not only allows us to manipulate these crypt cultures to answer scientific questions 
but could also have potential applications in regenerative medicine and in testing 
efficacy of pharmacological agents against cancer and other diseases (155). 
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Figure 1-6 Cell signaling at the base of the intestinal crypt. 
The schematic shows how growth factors such as Wnt, Notch and EGF supplied 
by the surrounding niche support the maintenance, proliferation and 
differentiation within the stem cell compartment. 
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Tan and Barker Seminars in Cancer Biology 32 (2015) 40–53 
Figure 1.6 
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Figure 1-7 Structural organization of in vitro cultures crypt derived 
organoids. 
 Schematic shows the arrangement of crypt and villus domains within in 
vitro cultured organoids. Stem cells are shown as green colored wedge 
shaped cells at the bottom of crypt domains. 
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Schuijers and Clevers. The EMBO Journal 31 (2012), 2685–2696 
 
Figure 1.7 
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1.6 Why study intestinal stem cells 
Their ability to continuously self-renew while generating progeny makes IESCs excellent 
candidates for use in regenerative medicine but this also makes them susceptible to 
accumulating cancer causing mutations. Thus, targeting self-renewal of this cancer 
causing stem like cell can serve as an effective therapeutic strategy (156).  
Progression of cancer from benign adenomatous polyps to highly aggressive 
carcinomas has been shown to be a function of continuous accumulation of mutations 
(157). From stem cell Cre based deletion of tumor suppressors or cancer stem cell 
xenograft transplantation experiments; substantial evidence has accumulated over the 
years to believe that normal stem cells can serve as the “cell of origin” within which 
accumulation of mutations can potentially result in colorectal cancer (58, 159-165). This 
is called the “bottom-up” model (155). Other observations that support this model 
include: the architecture of adenomas is very similar to normal crypts with the ability to 
differentiate into all the mature cell types being retained (166). Using lineage tracing, 
assessment of clonality upon activation of oncogenic KrasG12D revealed that much like 
their normal counterparts, mutated crypts moved towards fixation of a clone albeit the 
size of individual clones and drift towards monoclonality was much quicker, possibly due 
to increased cell cycle rates of the mutated cells. What was even more interesting to 
note was that because the stochastic dynamics of neutral drift remained intact, quite 
often WT clones were seen to replace mutant ones, demonstrating a mechanism by 
which the normal intestinal architecture attempted to thwart fixation of mutations. Also, 
similar to normal crypts, once fixed, mutated clones were seen to expand within the 
tissue through crypt fission (159, 160). Thus, it will be crucial to find ways to target these 
cancer stem cells without affecting normal stem cells. 
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1.7 CBL Family Ubiquitin E3 Ligase 
1.7.1 Evolutionary history and domain architecture of CBL proteins 
CBL (Casitas B-Lineage Lymphoma) was first identified as an oncoprotein, v-CBL, a Cas 
NS-1 retroviral Gag-fusion protein of 357 amino acids long that caused pre- and pro-B   
cell lymphomas in mice (167). Subsequent discovery of the full length cellular version, c-
CBL (913 a.a. in mice) revealed that v-CBL was C-terminal truncated form of the protein 
fused to viral Gag protein (168). Mammalian CBL family includes two other members 
namely CBL-B and CBL-C. While c-CBL and CBL-B are full length proteins, CBL-C is a 
shorter form lacking some of the key C-terminal domains (figure1.8) (169).  
The N-terminal region in all the three members comprises of a Tyrosine Kinase 
Binding (TKB) domain that recognizes a specific phospho-tyrosine (pY) motifs on 
activated receptor and non-receptor tyrosine kinases. The TKB domain is made up of a 
unique assortment of domains found only in CBL proteins. These include a four-helical 
bundle (4H), an EF hand and an SH2 domain (170). A highly conserved helical linker 
and RING (Really Interesting New Gene) finger domain follow the TKB region of CBL. 
Linker and RING finger domains bestow the E3 ligase function on to CBL proteins as 
they together serve as a scaffold for binding of E2, ubiquitin conjugating enzyme (figure 
1.9) (171). These three regions (TKB, Linker and RING finger) together comprise the N-
terminal domain of CBL proteins. In addition to the N-terminal domain, CBL and CBL-B 
also are comprised of a C-terminal tail made up of proline-rich (PR) and leucine-zipper 
(LZ)/Ubiquitin-Associated (UBA) domains. While the PR domain enables CBL and   
CBL-B to interact with SH3 domain containing proteins like Src-family kinases, Grb2 and 
CIN85, the LZ/UBA domain allows ubiquitination and dimerization of CBL proteins 
although its exact functional significance remains unclear (169). CBL and CBL-B also 
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harbor several key pY residues, which upon phosphorylation bind to SH2 domain 
containing proteins such as Vav, p85 subunit of PI3K and Crk family proteins (169).   
Evolutionarily, orthologs of CBL proteins have been found in all metazoan species 
with fairly similar domain structure. The most primitive organism to have a version of 
CBL has been traced back to a slime mold, Dictyostelium discoideum. Dicty-CBL has a 
conserved N-terminal domain architecture minus the linker region. Interestingly, this 
version of the TKB domain interacts with a protein tyrosine phosphatase, PTP3, and 
downregulates it to potentiate STAT signaling (172). While worms (Sli-1 of C.elegans) 
have a single CBL protein, insects (D-CBL (short) and D-CBL (long) of D. 
melanogaster), fish, amphibians and birds have two forms. All mammals on the other 
hand have three CBL proteins (169). 
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Figure 1-8 Evolutionary conservation of the primary structure and domain 
organization of CBL proteins. 
Comparison includes: the three human (Homo sapiens) CBL proteins (CBL; 
CBL-B; and CBL-C); Chicken (Gallus gallus) CBL; Zebra fish (Danio rerio) CBL; 
Frog (Xenopus tropicalis) CBL; Fly (Drosophila melanogaster) long and short 
CBL; Worm (Caenorhabditis elegans) CBL (SLI-1); and Dicty (Dictyostelium 
discoideum) CBL (Cbl-A).  
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Mohapatra et al., Biochimica et Biophysica Acta 1833 (2013) 122–139 
Figure 1.8 
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Figure 1-9 Domain architecture of CBL proteins and major interacting 
partners. 
 The N-terminal Tyrosine Kinase-Binding (TKB) domain binds to phospho-
tyrosine (pY)-containing target proteins, including activated receptor and non-
receptor tyrosine kinases. The Linker (L) and the RING finger (RF) regions bind 
to ubiquitin conjugating enzymes (E2). The proline-rich motifs (Pro-rich) bind to 
SH3 domain containing proteins such as Src family kinases (SFK). Recruitment 
of CBL to its targets often induces phosphorylation at tyrosine residues in the 
C-terminal region of the protein that further engages SH2 domain-containing 
signaling proteins. The Ubiquitin-associated (UBA) domain/leucine zipper near 
the C-terminus is involved in ubiquitin binding and dimerization.  
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Mohapatra et al., Biochimica et Biophysica Acta 1833 (2013) 122–139 
Figure 1.9 
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1.7.2 Function & localization of CBL proteins 
Numerous studies provided indirect evidence for the role of CBL in negative regulation of 
activated protein tyrosine kinases (PTKs); however, it was in 1997 that using oriented 
phosphopeptide libraries and mutagenesis we showed for the first time that the N-
terminal domain of CBL bound to the negative regulatory pY motifs of ZAP70 and Syk 
(173). Similar studies of TKB domain interaction of CBL were further extended to RTKs 
such as PDGFR and EGFR (174-176). Biochemical studies later established that CBL 
induced downregulation of activated RTKs by ubiquitination and lysosomal degradation 
of the internalized receptor (175, 177) could be attributed to the E3 ligase function of the 
RING finger domain (178). The generality of this ubiquitination related negative 
regulatory function of CBL was quickly extended to other RTKs such as c-MET and M-
CSFR, and non-receptor PTKs such as Fyn, Lck, Src, ZAP-70 and Syk (179-185). 
Structural and mutational studies have elucidated that while CBL attaches to its 
targets via the TKB or the proline-rich domains and the C-terminal pY residues; binding 
of E2 ubiquitin conjugating enzyme requires both Linker and RING finger regions. 
Particularly, phosphorylation of a critical tyrosine residue (Y371) in the linker region of 
CBL alters its conformation in a way that not only increases its binding to E2 but also 
brings E2 closer to the CBL targets (186). This association renders the PTK targets 
(multi) mono-ubiquitinated or polyubiquitinated, which are further sorted to lysosomal or 
proteosomal degradation (169). 
Localization studies mainly focused on c-CBL have shown that it is localized to the 
cytosol but can also be found on membrane due to its association with membrane 
receptors and membrane adaptor proteins (187). 
Few studies have gauged the physiological function of CBL proteins in a cell. In T 
cells, it was shown that CBL proteins regulated actin cytoskeleton needed for 
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stabilization of immunological synapse such that loss of CBL proteins led to prolonged 
synapses, resistance to induction of anergy, hyperactivation of the T-cell receptor 
(independent of co-stimulation from CD28), enhanced proliferation and cytokine 
secretion (169). CBL/CBL-B deficient mammary epithelial cells on the other hand were 
shown have increased migration upon being exposed to growth factors such as EGF or 
HGF, with no effect on proliferation (188).  In contrast, Cbl-/- or Cbl/Cbl-b double 
knockout (DKO) hematopoietic stem and progenitor cells showed marked increase in 
proliferation upon cytokine stimulation (189-191). 
In order to understand the physiological roles of CBL proteins, gene knockout mouse 
models have been helpful. It has been shown that while CBL and CBL-B are ubiquitously 
expressed in all tissues, expression of Cbl-c is restricted to epithelial tissues (169, 192). 
Cbl null mice, otherwise viable, show some hyper-cellularity in the lymphoid organs 
especially spleen, thymus and bone-marrow (190, 193, 194). Also, they display lean 
muscle mass due to elevated insulin action (195-196). In addition, males are hypofertile 
(196). Deletion of Cbl-b makes mice autoimmune when challenged by antigen due to 
hyperactivation of T and B cells (197, 198). Under pathogen-free laboratory conditions 
though, Cbl-b-/- have no apparent developmental abnormality (169). In addition, an 
interesting role of CBL-B (and possible of Cbl as well) as an inducer of muscle atrophy 
associated with its ability to downregulate insulin receptor signaling has emerged from 
the literature (199-202). Knockout of Cbl-c has not been associated with any anatomic 
observable phenotype (192, 203). In contrast, combined germ-line deletion of Cbl and 
Cbl-b results in embryonic lethality (203). Mice with germ-line double deletion of Cbl with 
Cbl-c and Cbl-b with Cbl-c have been recently generated in our lab and are viable. From 
unpublished observations in our lab, conditional whole body deletion of floxed Cbl and 
Cbl-b alleles using R26-CreERT in adult animals is also incompatible with life as mice 
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die within 5 days of tamoxifen induction due to complete breakdown of intestinal 
epithelial barrier. This suggests that CBL and CBL-B, the two full length proteins of the 
CBL family, play essential but possibly redundant roles during embryonic development 
as well as adulthood.  
Because of the functional redundancy of CBL and CBL-B, mice with conditional 
(floxed) Cbl alleles on a Cbl-b null background have been generated to study pertinent 
tissue-specific roles of CBL and CBL-B (189, 203). Using Lck-Cre to generate  
CBL/CBL-B DKO T cells heightened the autoimmune phenotype and hyper-
responsiveness of T cells to antigen stimulation as seen in CBL-B null mice (203). Loss 
of CBL/CBL-B in the B cells of mice led to a loss of peripheral tolerance (205). Even 
more remarkable results were seen in the case of hematopoietic stem cells where 
combined loss of CBL and CBL-B led to the development of myeloproliferative disorder 
(MPD) in mice which was fatal within 8 weeks of birth (189). A RING finger domain 
missense mutant knocked-into one allele and a complete loss of the other allele of Cbl 
phenocopied the DKO phenotype of MPD but at a significantly slower pace (191), 
illustrating that MPD resulted from the loss of E3 ligase activity of CBL. 
All together, these studies point to selective and redundant functions of CBL and 
CBL-B possibly linked to their relative expression within a tissue type. However, more 
studies are needed to better understand their roles especially in non-immune organ 
systems.  
1.7.3 CBL in Stem Cells and Cancer 
As mentioned before, CBL was first identified as a retroviral fusion oncoprotein (v-CBL) 
capable of inducing T- and B-cell lymphomas, erythroleukemia, and myeloid leukemia 
with a latency period of 5-6 months (167, 169). Two other oncogenic variants of CBL 
have since been identified in murine cell lines derived from carcinogen-induced 
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lymphomas (187) namely 70Z CBL (Linker-RING finger mutant incapable of binding to 
E2) and p95 CBL (hyper-phosphorylated form of CBL found near the membrane).  
In humans, mutations in the helical linker and RING finger domain have been 
reported in myelodysplastic syndromes such as juvenile myelomonocytic leukemia 
(JMML), chronic myelomonocytic leukemia (CMML) and atypical chronic myeloid 
leukemia (aCML) (206-210). Cbl mutations have so far not been reported for any 
epithelial cancers, although a recent report on Noonan Syndrome, a developmental 
disorder characterized by stunted growth, malformations of heart and facies, showed 
germ-line heterozygous deletion of Cbl as the cause (211).  
Over the last few years, published as well as unpublished data from our lab as well 
as from other studies have been pointing towards a very interesting role played by the 
CBL family of proteins in the regulation of stem/ progenitor compartments. In the 
hematopoietic system, we recently demonstrated that the earlier reported fatal MPD was 
a result of combined loss of CBL/ CBL-B within the hematopoietic stem cells (HSCs) and 
not the progenitors. In addition, we showed that CBL proteins were essential for 
maintenance of quiescence of HSCs such that DKO HSCs lost repopulation ability over 
time due to exhaustion (212).  In the neural system, one study showed the upregulation 
of CBL protein in response to oxidative stress in neural progenitor cells (213) while 
another study demonstrated that double deletion of Cbl and Cbl-b in the neural stem 
cells led to loss of asymmetric distribution of EGFR into daughter cells and increase in 
the number of neurospheres formed (214). With respect to osteoblast differentiation, it 
was shown that knock-down of Cbl in the mesenchymal stromal cells led to 
hyperactivation of STAT5 and thereupon increased differentiation to osteoblast cell fate 
(215). 
  
 
44 
Even though several epithelia relevant RTKs and non-receptor PTKs are targets of 
CBL proteins, no study has looked at their role in maintaining epithelial tissue. With this 
in mind, we generated conditional deletion of Cbl in the Cbl-b null background in the 
mammary gland using MMTV-Cre as well as WAP-Cre. DKO resulted in considerably 
reduced ductal branching. An in-depth investigation of this phenotype has revealed a 
significant reduction in the mammary stem cell population (CD24+/CD29hi) and a 
concomitant increase in the luminal epithelial population. This phenotype was confirmed 
with Lgr5-Cre based deletion of Cbl and Cbl-b in the mammary stem cells which showed 
shrinkage of the basal population (reported to harbor mammary stem cells) and 
expansion of luminal fate. With respect to the expectations of CBL’s role as a negative 
regulator of PTK signaling, the observed phenotype of delayed development of the 
mammary gland seemed counterintuitive especially keeping the hyper-proliferative HSC 
phenotype in mind. Thus, in order to investigate these tissue type specific differences in 
the role of CBL proteins in the epithelial stem/progenitor compartment, we proposed to 
study CBL proteins by employing the well characterized stem to mature epithelial cell 
hierarchy of the intestinal epithelium using the well-established Cbl fl/fl; Cbl-b-/- genetic 
system created by our lab. Not only would this study enhance our knowledge about the 
function of CBL proteins in the intestine but also provide mechanistic details to reconcile 
the divergent phenotypes of hematopoietic and mammary stem cells.  
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2 Materials and Methods 
2.1 Mouse Strains 
All mice used for experiments were approximately of 6-8 weeks of age. Lgr5GFP-
CreERT2 and Rosa26-LacZ reporter mice were purchased from Jackson Laboratories 
and interbred. This genotype served as a control. These mice were further bred with Cbl 
floxed; Cbl-b null mice (189) to obtain Cbl fl/fl; Cbl-b null; Lgr5-CreERT2; R26-LacZ 
experimental mice so that tamoxifen inducible stem cell specific deletion of Cbl and   
Cbl-b could be achieved. Cbl knockout (194)(198) and Cbl-b knockout (198) mice have 
been used to study the function of individual genes in the intestine with WT littermate 
C57BL/6J mice serving as controls. Cbl f/f; Cbl-b f/f; R-26-CreERT mouse model 
recently generated in our lab was used to perform organoid assay to by deleting  
Cbl/Cbl-b in vitro. 
All mouse strains were maintained on C57BL/6J background under specific 
pathogen-free conditions and handled in accordance with protocols approved by the 
Institutional Animal Care and Use Committee (IACUC) of UNMC. Mice were genotyped 
using tail DNA (primer sequences in Table-2.1).  
2.2 Induction of Gene Deletion 
Tamoxifen free base (MP Biomedicals, Catalog no. ICN15673880) was resuspended in 
sunflower oil (Catalog no. Sigma Aldrich, S5007) at a concentration of 10 mg/ml. 1ml 
Aliquots were made and frozen at -20°C.  
At 6 weeks of age, gender matched Lgr5-CreERT2; R26-LacZ and Cbl f/f; Cbl-b-/-; 
Lgr5-CreERT2; R26-LacZ mice were given intra-peritoneal injection of 2 mg of tamoxifen 
for 3 consecutive days to activate inducible Cre recombinase. Animals were analyzed 3 
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days after the last injection (or 5 days after the first), 8 days after the last injection (or 10 
days after the first) or 4 months after the last injection. 
2.3 Animal Euthanasia 
All mice used in this study were sacrificed by first anesthetizing using isoflurane (Piramal 
Healthcare, Catalog no. NDC66794-017-25) followed by cervical dislocation to confirm 
death.  
2.4 Tissue Harvest and Histological Analysis 
Mouse small intestine was excised carefully from the peritoneal cavity by first snipping at 
the ileo-cecal junction and pulling away to disentangle the intestine from the mesh of 
mesentery and finally cutting at the pyloric end of stomach. The intestine was 
immediately placed in a Petri dish, and gently flushed with cold phosphate buffered 
saline (PBS) to remove fecal matter using a 30 ml syringe and a blunt ended needle. 
Once cleaned, intestine was kept on a blotting sheet, cut open longitudinally, swiss- 
rolled and placed in formalin (Sigma Aldrich, Catalog No.HT501128) for overnight 
fixation at room temperature. Fixed tissue was processed, embedded in paraffin and 
sectioned to 5 uM thickness.  
2.5 Immunofluorescence (IF) 
Tissue sections were de-paraffinized and rehydrated followed by antigen retrieval in 
sodium citrate antigen unmasking solution (Vector Laboratories) using microwaving for 
20 min. Slides were then washed in PBS and blocked for 1 hr in TBS-T (Tris Buffered 
Saline with 0.1% Tween-20) containing 5% goat serum (Sigma Aldrich, G9023) followed 
by overnight incubation at 4°C with optimized concentrations of primary antibodies 
{(BrdU, Developmental Studies Hybridoma Bank, Iowa, G3G4,1:25) , Chromogranin A 
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(1:200, Abcam, Catalog No.15160 ), Cleaved Caspase 3 (Cell Signaling, Catalog 
No.9664, 1:200), GFP (Cell Signaling Rabbit monoclonal, 2956, 1:200), GFP ( Chicken, 
Catalog No.1020, Aves Laboratories, 1:2000)}. Tissue sections were then washed thrice 
in PBS for 5 minutes each, followed by incubation with fluorescently-tagged secondary 
antibodies (Molecular Probes Alexa series, all 1:400 in blocking buffer) for 1 hr at room 
temperature, washed 3X with PBS and mounted with Vectashield with DAPI to stain 
nuclei (Vector Laboratories). 
2.6 Immunohistochemistry (IHC) 
Tissue sections were de-paraffinized and rehydrated followed by antigen retrieval in 
sodium citrate antigen unmasking solution (Vector Laboratories) using microwaving for 
20 min. Slides were then washed in PBS and kept in 5% H2O2 for blocking endogenous 
peroxidase for 1 hour at room temperature. Slides were washed with PBS and blocked 
using Mouse Ig Blocking Reagent from Mouse on Mouse (MOM) kit of Vector 
Laboratories for Cbl (mouse monoclonal, anti-Cbl, BD Bioscience, 1:400) and Cblb 
(mouse monoclonal, anti-Cblb, Abcam, 1:100) or using 5% goat serum (Sigma Aldrich, 
G9023) for ChromograninA (1:200, Abcam) and Ki67 (Rat eBioscience, 145698-82, 
1:200) for 1 hour at room temperature. Slides were washed twice with PBS and 
incubated with primary antibodies mentioned above for overnight at 4°C. The next day, 
slides were washed thrice with PBS for 5 min each and incubated with biotinylated 
secondary antibodies. ABC amplification IHC kit (Vector Laboratories) was used as per 
vendor’s instructions to amplify the signal. Slides were washed twice and peroxidase 
staining was developed using DAB (3,3’-diaminobenzidine, Vector Laboratories) as HRP 
substrate. The slides were counterstained with hematoxylin, dehydrated and mounted in 
automated counter-stainer (Sakura Tissue-tek Prisma) at the UNMC Tissue Science 
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Core Facility. In all cases, a species matched isotype IgG or genetic knockouts were 
used as a negative control. 
2.7 β-Galactosidase (LacZ) Staining 
Protocol published by Barker and Clevers was used to perform lineage tracing using 
LacZ staining (216). Briefly, freshly dissected intestinal tissue was flushed clean with 
cold PBS and fixed in Gluteraldehyde fixative (1% formaldehyde, 0.2% gluteraldehyde, 
0.02%NP-40 in PBS) for 2 hours at 4°C. Tissue was washed twice with PBS and 
incubated in equilibration buffer (2mM MgCl2, 0.02% NP-40, 0.01% sodium 
deoxycholate in PBS) for 30 minutes at room temperature. After this, equilibration buffer 
was replaced by LacZ substrate {5mM K3Fe(CN)6 , 5mM K4Fe(CN)6, 2mM MgCl2, 
0.02% NP-40, 0.1% sodium deoxycholate, 1mg/ml X-gal in PBS} and incubated for 4 
hours at 37°C away from light. After blue color developed, tissue was washed twice with 
PBS, swiss rolled and incubated in 4% paraformaldehyde at 4°C overnight. Next 
morning, fixative was removed and tissue was washed with PBS and dehydrated in 
alcohol gradient (70%, 96% and 100% for 1 hour each) and paraffin embedded. 5uM 
tissue sections were cut, paraffin cleared and rehydrated, followed by counterstaining 
with nuclear fast red (Vector Labs).  
2.8 Intestinal stem cell isolation and flow cytometric analysis 
A modification of the Intestinal stem cell consortium protocol was used for making stem 
cell enriched single cell suspension of intestinal epithelium (217). Briefly, freshly 
dissected intestinal tissue was flushed clean with ice cold washing buffer (100 µg/ml 
penicillin/streptomycin, 10mM HEPES, 2mM Glutamax in HBSS) and cut open 
longitudinally to expose the lumen. A glass coverslip was used to scrape off the villi and 
the tissue chopped into 5 mm long pieces. The chopped pieces were then washed 
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several times with cold washing buffer by vigorously pipetting until the supernatant was 
almost clear. After this, the tissue was placed in dissociation reagent #1 {15mM EDTA, 
1.5 mM DTT, 10µM ROCK inhibitor (Y27632, TOCRIS), 100 µg/ml 
penicillin/streptomycin, 10mM HEPES, 2mM Glutamax in HBSS} and rocked slowly at 
4°C for 30 minutes. Supernatant was removed and replaced with fresh cold washing 
buffer and the tube was shaken vigorously. Tissue pieces were allowed to settle down 
and supernatant was passed through 70µM cell strainers and centrifuged at 1200 rpm 
for 5 minutes at 4°C. The pellet was resuspended in 10 ml washing buffer and 
centrifuged at 600 rpm for 2 minutes at 4°C. The cell pellet obtained was incubated in 
dissociation reagent # 2 {TrypLE Express (thermo scientific) 1:2 dilution, 10µM ROCK 
inhibitor (Y27632, TOCRIS), 0.5 mM N-acetylcysteine (Sigma), 200 µg/ml DNAaseI in 
Intestinal Epithelial Stem Cell Media (IESC Media) (Advanced DMEM/F12 supplemented 
with 1X N2 (invitrogen), 1X B27 without vitamin A (invitrogen), 10 mM HEPES, 2mM 
Glutamax (invitrogen),100 µg/ml penicillin/streptomycin} for 8 minutes at 37°C, pipetting 
intermittently to reduced cell clumping. Equal volume of neutralization buffer (10% FBS 
in IESC Media) was added to the tubes and the cell suspension was passes through 
20µM cell strainers. Followed by this, cells were centrifuged at 1000 rpm for 5 minutes at 
4°C. Supernatant was discarded and cells were resuspended in 1 ml of cold IESC media 
and counted under a microscope. After assessing the yield, cells were stained by 
incubating with Alexa 700 conjugated anti-CD45 antibody (BioLegend, Catalog No. 
103128, 0.25 µg per 106 cells) at 4°C for 30 min. Cells were washed twice after that and 
propidium iodide was added to the cells before analyzing using  BD LSR2 instrument. 
Post data collection, further analysis was done using BD FACS DIVA software. 
In another analysis, single intestinal epithelial cells were stained with fixable-Blue 
LIVE/DEAD stain (invitrogen) using manufacturer’s protocol. Cells were then washed 
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and stained for DLL1 using DLL1-PE (ebioscience, Caalog No. 12-5767-80, 0.25 µg per 
106 cells) antibody by incubating at 4°C for 30 min. Cells were washed twice after that 
and analyzed using  BD LSR2 instrument.  
2.9 RNA Isolation, cDNA synthesis and quantitative PCR 
analysis 
Flow analyzed cells were directly sorted into 500 µl of RNA lysis buffer of  RNAqueous®-
Micro Total RNA Isolation Kit from Thermo Scientific (Catalog No. AM1931). Instructions 
from the kit were followed to isolate RNA. Yield of RNA was assessed using nanodrop 
instrument and cDNA synthesis kit from QIAGEN was used to make cDNA (catalog No. 
205311). QuantiTect SYBR® Green PCR Kit was used to perform real-time PCR 
analysis on a Bio-Rad CFX-96 Thermo Cycler. Primer sequences (obtained from Sigma-
Aldrich) are listed in Table 2.2. Relative gene expression was calculated according to the 
ΔCt method, and normalized to GAPDH reference gene expression.  
2.10 Lysate preparation and Western Blot 
Freshly-excised, cleaned and chopped fragments intestine were incubated in 2mM 
EDTA in cold PBS at 4°C for 30 minutes to isolate intestinal epithelium from the 
remaining tissue. Once epithelial layer was separated (by shaking vigorously and taking 
the supernatant), it was pelleted and homogenized using a Pro-Sientific homogenizer in 
RIPA lysis buffer 50mM Tris Chloride (pH 7.5), 100 mM NaF, 0.1% SDS, 1 mM EDTA, 1 
mM PMSF, 10 μg/ml Aprotinin, 10 μg/ml Leupeptin, 1 mM Na3VO4, and NP-40 0.02%). 
Intestinal organoid lysates were prepared in the same lysis buffer. Further lysates were 
quantified using BCA kit from Thermo Scientific. 40 µg of lysates were resolved on 8% 
SDS–PAGE and transferred to PVDF membranes, which were then blocked with 2% 
BSA in TBS-T and incubated overnight at 4°C with specific antibodies diluted in TBS-T. 
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The following antibodies were procured from commercial sources: Mouse monoclonal 
antibody (mAb) anti-Cbl (Clone 17/c-Cbl, BD Bioscience); Rabbit monoclonal antibody 
(mAb) anti-Cbl-b (Clone D3C12, Cell Signaling Technology); Mouse monoclonal 
antibody (mAb) anti-HSC70 from Santa Cruz Biotechnology Inc. (Clone B6, Santa Cruz, 
CA). Membranes were washed 3X in TBS-T, incubated with HRP-conjugated species 
specific secondary antibodies (Zymed Laboratories, South San Francisco, CA) and 
signals were detected with Pierce ECL substrate (Thermo scientific). 
2.11 Abdominal Radiation 
Mouse irradiation was accomplished on the TrueBeam linear accelerator in the 
Radiation Oncology Department at UNMC. Mice were first sedated with 
Ketamine/Xyalzine, restrained to prevent movement to ensure reproducible positioning 
for radiation and imaged using the simulation CT scanner. The radiation target 
abdominal region was contoured and mice were exposed to a dose of 14Gy X-ray 
radiation. 
2.12 Organoid Culture 
A modification of the organoid protocol from Sato et al. was used for making organoids 
from crypts of R-26 CreERT; Cblf/f; Cblbf/f mice (49). Freshly dissected, cleaned and 
chopped fragments of ileum were incubated in 2mM EDTA in cold PBS at 4°C for 30 
minutes in a 15ml Falcon tube. Tissue fragments were allowed to settle, supernatant 
was replaced with washing buffer (recipe mentioned under section 2.8) and the tube was 
shaken by hand for 3 minutes to release epithelial layer from the remaining tissue. 
Supernatant was passed through 70μM cell strainer and rinsed with fresh washing 
buffer. Crypts were counted under the microscope and volume containing 500 crypts/ 
well was pelleted. Supernatant was removed and crypts were resuspended in Matrigel 
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(BD Bioscience, Catalog No. 356237) mixed with growth factors (EGF 5ng/ml; Noggin 
100ng/ml; R-spondin 500 ng/ml) and plated in a 24 well plate (Costar) which was then 
kept at 37°C to polymerize for 15 minutes. Wells were filled with 500μl of IESC media 
(recipe mentioned under section 2.8). Spent medium was replaced on the 4th day after 
plating with IESC containing EGF, Noggin, R-spondin 1 conditioned medium (1:10) and 
Wnt-3a conditioned medium (1:10). HEK293 cells, which overexpressed recombinant R-
spondin1 were a gift from Dr. Mark R. Frey   and Wnt-3a overexpressing L cells were 
purchased from ATCC.  
After the first passage, organoids from Cre positive and Cre negative control mice 
were split in a 1:4 ratio and grown for another 4 days at which point media containing 
400 nM 4-hydroxitamoxifen (4-OHT) (Sigma) was added and organoids remained in it for 
the next 72 hours before they were re-passaged or used for experiments. 
2.13 Statistical Analysis 
Statistical analysis was performed using Paired two-tailed student’s t-test to compare the 
results between control and knock-out mice. Data are presented as average values + 
SEM. The results were considered significant if P< 0.05.  
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Table 2.1 Genotype Primers 
Gene Forward 5’-3’ Reverse 5’-3’ 
Cbl WT AAGTTCCAAGCCTAGCCAGATA 
TGTGTGTG 
TCCCCTCCCCTTCCCATGTTTTT
AATAGACTC 
Cbl Del TGGCTGGACGTAAACTCCTCTT 
CAGACCAATAAC 
TCCCCTCCCCTTCCCATGTTTTT
AATAGACTC 
Cbl floxed GTGGTGGCTTGCAATTATAATC 
CTACCACTTAGG 
GTTTGAGATGTCTGGCTGTGTAC
ACGCG 
Cbl-b del CCCAGCAAAAGTAGCCAATG CTTGCAAAAAGGACTAAGATTC 
Cblb floxed GGCAGAACCACTGAGACACAT
TTA 
GGCTGCCAAACTGCTACCCAGG
AG 
Lgr5 - 
CRE ERT2(WT) 
CTGCTCTCTGCTCCCAGTCT ATACCCCATCCCTTTTGAGC 
Lgr5- 
CRE ERT2 
(Mutant) 
CTGCTCTCTGCTCCCAGTCT GAACTTCAGGGTCAGCTTGC 
Cre  GCGGTCTGGCAGTAAAAACTA
TC 
GTGAAACAGCATTGCTGTCACTT 
R26-LacZ 
(WT) 
AAA GTC GCT CTG AGT TGT 
TAT 
GGA GCG GGA GAA ATG GAT 
ATG 
R26-LacZ 
(Mutant) 
AAA GTC GCT CTG AGT TGT 
TAT 
GCG AAG AGT TTG TCC TCA 
ACC 
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Table 2.2 Primers used for quantitative real-time PCR 
Gene Forward 5’-3’ Reverse 5’-3’ 
Cbl AGCTGATGCTGCCGAATTT TTGCAGGTCAGATCAATAGTGG 
Cbl-b GGAGCTTTTTGCACGGACTA TGCATCCTGAATAGCATCAA 
GAPDH CCTGGAGAAACCTGCCAAGTATG AGAGTGGGAGTTGCTGTTGAAGT 
DLL1 CCCATCCGATTCCCCTTCG GGTTTTCTGTTGCGAGGTCATC 
Nurog3 GAGTCGGGAGAACTAGGATG CAGTCCCTAGGTATGAGAGT 
Alpi ATCCATCTGTCCTTTGGTATC TGATGAGGTTCTTAGCTGAT 
Lgr5 AACGGTCCTGTGAGTCAACC ATGGGGTAAGCTGGTGATGC 
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3 Results 
3.1 CBL proteins are expressed in a gradient along the crypt-
villus axis 
In order to study the role of CBL proteins in the maintenance of intestinal epithelium it 
was imperative to understand their expression pattern. Thus, in the absence of any 
previously reported study on CBL proteins in the intestine we began by analyzing the 
expression of CBL and CBL-B through immunohistochemistry, immunoblotting and 
quantitative real-time PCR. Due to the lack of reagents to study CBL-C at the protein 
level, we made use of the Cbl-c knockout mouse model (192), which has a knock-in of 
LacZ into the Cbl-c locus.  These mice were crossed to Lgr5-GFP-CreERT2 mice and 
this model was used to study the expression of Cbl-c at mRNA level. Lastly, by 
employing Cbl, Cbl-b and Cbl-c single knockout mice we sought to learn about the 
possible compensation at the transcript level between Cbl family members.  
Immunohistochemical (IHC) staining for Cbl on tissue sections from 6 week old WT 
and Cbl-/- mice revealed that CBL was expressed in an increasing gradient from villus to 
crypt. Cbl null animal was used as a negative control for the staining (figure3.1a, b). 
Using the same technique to study the expression of CBL-B, we found a similar pattern 
of increasing gradient of expression for CBL-B from villus to crypt, although it was less 
obvious in this case (figure3.1c, d).  To confirm our findings of IHC, we prepared 
mucosal whole tissue lysates from different regions of the intestinal epithelium, with one 
fraction being enriched in crypts and the other in villi (figure3.1e, f). We found both the 
proteins to be substantially enriched in the crypts vs. villi and much like the IHC, Cblb 
was more highly expressed in the villi than CBL. Phospho-histone3 (pH3) and CyclinD1 
are markers of proliferation to be found only within the crypt while Villin is ubiquitously 
expressed although more enriched in villus vs. crypt. These three proteins were probed 
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to validate the fractions prepared. HSC70, a housekeeping protein was used as a 
loading control. To study the expression of Cbl-c, LacZ and GFP co-stainings were 
performed on 6 weeks old Cbl-c-LacZ/LacZ; Lgr5-GFP-CreERT2 mice (Fig3.1g). While 
GFP antibody marked the Lgr5 expressing CBCs and their progeny (still retaining 
residual GFP protein) in the crypts, Lac Z (Cbl-c) was mostly localized to the 
differentiated cells on the villi. This pattern was in agreement with the previously 
published report on Cbl-c (192). In figure 3.1h-i and we scraped mucosal tissue from 
the luminal surface of the intestine to perform real-time PCR for Cbl and Cbl-b on the 
samples from WT, Cbl-/-, Cbl-b-/- and Cbl-c-/- mice. GAPDH was used as a 
normalization control. Cbl expression increased by more than 5 fold in Cbl-b-/- while it 
increased by about 2 fold in Cbl-c-/- mice as compared to the WT. Cbl-b expression was 
increased by about 2 fold in both Cbl-/- and Cbl-c-/- mice as compared to WT. This trend 
of compensation of expression in single null animals could be suggestive of functional 
redundancy between Cbl family members.  
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Figure 3-1 Expression analyses of CBL family members. 
Immunohistochemical (IHC) staining for CBL on tissue sections from 6 week old 
WT and Cbl-/- mice reveals that CBL  expresses in an increasing gradient from 
villus to crypt (a, b). A similar expression gradient is seen for CBL-B (c, d). Crypt-
villus fractionation confirmed enrichment of CBL and CBL-B within the crypts by 
immunobloting (e, f). Cbl-c expression analysis using LacZ-knock-in mice showed 
predominant expression within the villi, IHC for Lgr5-GFP in these mice marked 
the crypt compartment and showed no overlap between the two staining (g). 
Relative expression levels of Cbl, and Cbl-b mRNA in WT, Cbl-/-, Cbl-b-/- and 
Cbl-c-/- murine mucosal epithelium was assessed (h, i). GAPDH was used as a 
normalization control. Compensation of expression in single null animals is 
suggestive of functional redundancy between Cbl family members. Figures 3.1 a-
g were repeated three times on three different samples. Figure 3.1 h-i were 
performed twice on two different samples.   
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Figure 3.1a Figure 3.1b 
Figure 3.1c Figure 3.1d 
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Figure 3.1e Figure 3.1f 
Figure 3.1g 
Figure 3.1h Figure 3.1i 
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3.2 Cbl null mice show increased proliferation and 
differentiation to goblet cell fate  
Since Cbl-c expression was localized mostly to differentiated cells, and the main focus of 
our work was to determine the role CBL proteins in the mechanism of maintenance of 
intestinal epithelium, we decided to focus on the two full length proteins CBL and CBL-B 
that were enriched in the crypts, the epicenter of regenerating epithelium in the intestine. 
To begin our investigation, we looked at the gastrointestinal tissue from 6 weeks old  
Cbl-/- and Cbl-b-/- mice. While Cbl-b-/- looked indistinguishable from the WT, Cbl-/- 
showed goblet cell hyperplasia as revealed by PAS staining (figure3.2 a-e). 
Short term BrdU (bromodeoxyuridine) pulse of 4 hours was used to analyze the 
number of proliferating stem and progenitor cells in the crypts of WT and Cbl-/- mice 
(figure 3.2f-h). We found that in the absence of CBL there was a modest increase in the 
BrdU+ cells as compared to the WT. 
3.3 Construction and validation of Lgr5+ stem cell specific 
knockout model of Cbl/Cbl-b 
As mentioned before, combined complete genetic knockout Cbl and Cbl-b is not viable 
(203); thus, we decided to make an inducible DKO of these two genes in the Lgr5+ stem 
cell compartment by crossing together Cbl f/f; Cbl-/- mice (previously generated in our 
lab to probe the role of these proteins in hematopoietic stem cells and mammary stem 
cells) (189, 212) (Mohapatra et al., unpublished) with Lgr5-GFP-CreERT2 mice (13) that 
had already been mated with R26-LSL-LacZ reporter mice. Lgr5-GFP-CreERT2 mice 
are an ingenious genetic model used widely in intestinal epithelial biology to study Lgr5+ 
stem cells as they express GFP as well as a tamoxifen inducible Cre recombinase under 
the Lgr5 promoter.  
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Figure 3-2 Histological analyses of Cbl-/- and Cblb-/- mice. 
PAS staining on tissue sections from age matched WT, Cbl-/- , Cblb-/- mice 
revealed a significant  increase in the number of goblet cells with no change in 
Paneth cell number  in the Cbl null mice (a-e). WT and Cbl-/- mice subjected to a 
short pulse (4 hour) of BrdU showed increased commitment to S phase of the cell 
cycle in the Cbl null mice    (f-h). The experiments were repeated four times. 
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WT  Cbl-/-
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Figure 3.2f Figure 3.2g 
Figure 3.2h 
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Based on the relative expression of GFP researchers can study not just stem cells (GFP 
high expressors) but also their early progeny in which GFP has not yet completely 
decayed (GFP low expressors). Introduction of floxed Cbl and null Cbl-b alleles into 
Lgr5-GFP-CreERT2 mice allowed us to monitor self-renewal of Lgr5+ stem cells by 
tracking GFP expressing cells. In addition, inserting R26-Lox-Stop-Lox-LacZ reporter 
allele into these mice allowed us to not only track deletion of Cbl but also perform 
lineage tracing of Lgr5+ stem cells in which activation of Cre had taken place.        
Figure 3.3a shows the all the alleles introduced into our experimental mouse model. To 
perform experiments on these mice, we injected them with 2 mg of tamoxifen (TAM) 
mixed in sunflower oil intraperitoneally for three consecutive days and analyzed them at 
various time points indicated in Figure 3.3b. Also mentioned in figure 3.3b are the 
genotypes used in the following experiments. In order to validate correct workings of our 
mouse model, 72 hours after the last injection, we sorted live epithelial cells into two 
fractions based on their relative expression of GFP namely Hi (GFP-high) and Lo (GFP-
low) in addition to sorting GFP negative (GFP
-ve
) fraction which could potentially 
represent differentiated progeny that had lost GFP expression and performed qPCR for 
Cbl and Cbl-b in WT and inducible DKO (iDKO) mice (figure3.3. c-d). This experiment 
showed that relative to GFP
-ve 
cells in the WT mice, Cbl and Cbl-b were both most 
highly expressed in the GFP-Hi cells and tamoxifen treatment was successful in deleting 
Cbl within the Lgr5 compartment. Deletion of Cbl was also confirmed by performing IHC 
for the same proteins (figure3.3 e). As was seen in the qPCR analysis, expression of 
Cbl was not completely gone and this was because while half of the crypts showed loss 
of CBL, the expression remained intact in the other half of the crypts. This is in 
accordance with the published reports of the CreERT2 construct of Lgr5 being 
epigenetically silenced in about half of the crypts (13).  
  
 
65 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-3 Generation and validation of stem cell specific Cbl/Cbl-b iDKO 
mouse model. 
 Schematic shows targeted alleles used to generate conditional DKO animals (a). 
Conditional deletion of floxed Cbl alleles on a Cbl-b null background in Lgr5+ cells is 
carried out by using TAM inducible Lrg5-CreERT2. R26-LSL- LacZ is used as a 
reporter. Schematic of experimental plan followed and genotypes used (b). 
Tamoxifen induced mosaic deletion of Cbl demonstrated by IHC and real time PCR 
while Cblb is constitutively knocked out (c-e). Experiments shown in figure 3.3 c-e 
were repeated three times. 
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3.4 iDKO mice show increased proliferation with no alteration 
in apoptosis 
WT and iDKO animals were subjected to TAM injection as mentioned above. On 5th and 
10th day after treatment mice were injected with 2mg of BrdU and analyzed for 
proliferation changes. There was a significant increase in proliferating cells in iDKO vs 
WT after 5d of Cbl/Cbl-b loss and the trend looked similar at 10d after TAM (figure3.4 a-
f). In order to assess any changes in cell death, tissue sections from mice of both 
genotypes were stained with cleaved caspase 3 antibody. No significant difference was 
observed in the number of apoptotic cells in WT vs iDKO (figure3.4 g-k). 
3.5 iDKO mice show expansion of progenitor population at the 
expense of Lgr5+ stem cells 
To study the function of CBL proteins in the maintenance of stem cells we analyzed the 
impact of their loss on the percentage of GFP expressing Lgr5+ cells. For this 
experiment, crypts were isolated and dissociated into single cells from WT and iDKO 
mice after 5 and 10 days of induction. Single cells were subjected to flow cytometric 
analysis according to gating strategy delineated in figure 3.5 a-h.  We found that at 5 
days after TAM induction there was a significant reduction in the number of GFP Hi stem 
cells and a concomitant increase in the number of GFP Lo progenitor cells (figure3.5 a-
d).  Figure 3.5 e-h shows unstained and single stained controls for one representative 
experiment done at 5 days after TAM. A similar trend of reduction of GFP Hi cells and 
increment in GFP Lo cells was observed at day 10 after TAM treatment (figure3.5 i-j). 
Combining experiments from 4 independent experiments we found that there was a 
significant reduction in the percent GFP Hi Cells and an increase in GFP Lo cells at both 
the time points (figure3.5 k-n). Together with the proliferation analysis, this interesting 
observation pointed towards increased commitment towards differentiation in the iDKO 
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Lgr5+ stem cells. This loss of stem cells was however temporary, as progenitor 
population de-differentiated to give rise to GFP+ stem cells when analyzed at 2 months 
after TAM (figure 3.5 o).   
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Figure 3-4 iDKO animals show increased proliferation with no change in 
apoptosis. 
BrdU staining after short pulse showed significant increase in commitment to S 
phase of cell cycle after 5 days and 10days of TAM treatment (a-f). Cleaved 
caspase 3 immunostaining revealed no change in number of dead cells in WT 
vs iDKO at 10d time point. Each experimental time point  was repeated three 
times.  
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Figure 3-5 Loss of Cbl/Cbl-b coerces stems cell to undergo exhaustion. 
Flow cytometric analysis of live epithelial cells showed a significant expansion of Lgr5-
GFP Lo (progenitor) cells and a concomitant decrease in Lgr5-GFP Hi (stem cells) at 5 
days    (a-d; k-l) and 10 days  (i-j; m-n) after TAM induction in iDKO mice vs. WT. 
Unstained and single stained controls are shown to delineate the gating strategy 
followed (e-h). This loss of stem cells is overcome once the effect of TAM subsides as 
analyzed here at 60d after treatment (o) exemplifying the plasticity within the crypt. Each 
time point was repeated four times. 
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3.6 Loss of Cbl/ Cbl-b promotes commitment to differentiation 
Since the GFP analysis revealed that there was an increase in Lgr5-GFP Lo progenitor 
population and with no change in cleaved caspase 3+ apoptotic cells in the crypt, we 
suspected that these iDKO progenitors must be moving towards a more committed fate. 
To probe this further, we performed lineage tracing of iDKO and WT Lgr5+ cells by 
analyzing the expression pattern of β-galactosidase (LacZ) expressed under ubiquitous 
Rosa26 promoter. Upon TAM induction, removal of the stop cassette flanked by LoxP 
sites by Cre-recombinase expressed in the Lgr5+ cells allows transcription and 
translation of LacZ not only in the recombined stem cells but also in their progeny. Using 
this strategy we found that at 5 d and 10 d time points there was an increase in blue X-
gal (substrate of LacZ) staining in the crypts and villi (figure3.6 a-d). Quantitative 
analysis of these data showed that there was an increase in the partially blue and 
completely blue crypts but a reduction in the crypts with a single blue cell at 10 d time 
point (figure3.6 e-f).  This single stained LacZ+ cell most likely represents the Lgr5+ 
quiescent secretory progenitor cell (36, 37, 219). This finding was particularly interesting 
because in the literature, the quiescent secretory progenitor is responsible for 
repopulating IESC upon damage to the latter (36, 37, 219). However, in the absence of 
CBL proteins it appeared that these quiescent secretory cells may have also 
differentiated. Markers for this pool of quiescent progenitor cell are DLL1 (Delta like 
ligand 1) and Ngn3 (Neurogenin 3) (37, 38, 87). Real-time PCR revealed that there was 
a reduction in the expression of these markers in the Lgr5-Hi fraction after 5 days of 
TAM confirming the LacZ findings (figure3.6g, h). Percentage of DLL1 expressing GFP+ 
cells was further assessed after 10d TAM treatment using flow cytometry. Overall, the 
loss of CBL proteins seemed to have directed stem as well as quiescent progenitor cells 
towards differentiation.         
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Figure 3-6 Lineage tracing reveals increased commitment to differentiation in 
iDKO mice. 
 X-Gal staining showed increased commitment to differentiation in iDKO mice at 5 (c) 
and 10 (d) days post TAM induction as compared to WT mice (a-b). Quantitative 
analysis of the staining showed increase in the percentage of whole and partially blue 
crypts but a reduction in crypts with single blue cell, representative of the quiescent 
Lgr5 compartment (e-f). To confirm the loss of quiescent progenitor population, real-
time PCR showed a reduction in both DLL1 and Neurogenin3 secretory progenitor 
markers (g-h). Flow cytometric analysis of GFP+ DLL1+ cells at 10d after TAM 
induction showed a precipitous drop in iDKO vs. WT (i). Experiments shown in figure 
3.6 a-d were repeated 4 times per time-point. Real-time PCR analysis in figure 3.6 
was repeated 2 times. Flow analysis for GFP/ DLL1 dual positive cells was repeated 
twice. 
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3.7 iDKO mice show goblet cell hyperplasia at the cost of 
Paneth cells.  
Epithelial lining of the intestine is comprised of multiple functional cell types, most 
abundant of which are enterocytes. Indeed we found an increase in expression of 
alkaline phosphatase (ALPI) mRNA, a marker of enterocytes (figure3.7a).   
Of the secretory lineage of cells, iDKO mice showed a significant increase in the 
number of LacZ-PAS dual+ goblet cells and a concomitant reduction in the number of 
LacZ-PAS dual + Paneth cells (figure3.7b-d). Co-staining of LacZ and ChromograninA 
revealed no significant difference in the number of enteroendocrine cells (figure3.7e-g). 
Thus, loss of CBL proteins skewed stem cell differentiation towards enterocytic and 
goblet cell fate. 
 
 
 
 
 
 
 
 
 
 
 
  
 
86 
Figure 3-7 iDKO stem cells show increased commitment towards Enterocyte and 
Goblet cell fate and a reduction in Paneth cells. 
After 10 days of TAM induction, PAS and X-gal co-staining in iDKO mice revealed 
significant increase in commitment to goblet cells with a reduction in Paneth cell (b-d) 
while q-PCR showed increased expression of ALPI in the progenitor and differentiated 
cells (a). IHC of ChromograninA+ enteroendocrine cells on X-gal stained sections 
showed no difference in their number (e-g). These experiments were repeated four 
times. 
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3.8 DKO mice show delayed recovery of injured mucosa in 
abdominal radiation model 
Regeneration of lost cells in the intestinal epithelium under normal homeostasis is 
extremely important to maintain the epithelial barrier that prevents potential pathogens to 
infiltrate internal organs of our body. This process becomes even more crucial in case of 
mucosal insults such as exposure to radiation. Radiation induces cell death of 
proliferating cells by introducing double stranded breaks into the genetic material of 
these cells and because stem and absorptive progenitor compartment of the gut are 
both cycling in nature, it is one of the most severely affected organs by this kind of injury. 
Under these circumstances, the quiescent secretory progenitor is thought to re-enter the 
cell cycle and regenerate lost stem cells that can then take over the process of 
establishing epithelial homeostasis again.  
Most studies subject mice to whole-body radiation, however, this treatment severely 
compromises their bone marrow resident hematopoietic stem cells and they die at 
moderate to high doses of 10-12Gy because of hematopoietic complications (220). In 
order to understand the ability of iDKO Lgr5+ stem and progenitor compartment to 
differentiate and repopulate the epithelia following injury damage, we subjected 
experimental and control mice to 14 Gy of abdominal radiation to kill a majority of the 
proliferating Lgr5+ stem cells. Because of the mosaic expression of Lgr5-Cre, we chose 
a particularly high dose of radiation so that we could reduce regeneration from Cre 
negative crypts. Abdominal radiation has been used by few researchers to avoid 
hematopoietic toxicity and effectively target gut epithelium with 100% recovery of the 
animals due to re-establishment of epithelia by the gut stem cells (221). To perform 
abdominal radiation, we subjected anesthetized mice to CT scanning using the 
simulation CT scanner located in the Radiation Oncology Department at the University of 
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Nebraska Medical Center. The CT images were then used to identify the radiation target 
(small and large intestine) and organs at risk (stomach, liver and spleen) and treatment 
was contoured to avoid hitting anything other than the bowel by radiation (figure3.8 a, 
b).  
After the planning, mice received conformal radiation at a dose of 14Gy. WT mice 
were first used to validate this method. In figure3.8 c, we can see that as compared to 
un-irradiated control mice, at 3 d post radiation, crypts are obliterated in all the regions of 
the intestine. By day 5, the surviving clones begin the process of repopulation and by 
day 7 the mice are well on their way to recovery. After validating every step of this 
treatment plan in our hands, we subjected WT and age matched iDKO to radiation and 
TAM treatment. The latter was continued for another 2 days and mice were analyzed on 
the 7th day after radiation.  Mice were weighed every day as weight loss is good indicator 
of mucosal health (221). Figure3.8 d shows the treatment plan followed and figure3.8 e 
shows weight loss trends of WT, iDKO and Cbl-b-/- mice. At day 7 iDKO mice showed 
delayed recovery of injured mucosa as evidenced by blunted villi and various bare crypt-
less regions shown in figure3.8f. Next, tissue sections from these mice were stained 
with Ki67 proliferation marker and the average number of surviving crypts (defined as a 
crypt with at least 5 adjacent Ki67+ cells) was determined (35). Figure3.8 g-i shows 
there was a significant reduction in the surviving crypts in the iDKO mice. Figure3.8 j-n 
shows that the same trend that we observed previously of loss of Lgr5-Hi cells and a 
moderate increment of Lgr5-Lo cells. Sorting of GFP+ cells and analysis by qPCR for 
differentiation markers revealed that as compared to the WT animals there was a drop in 
expression ALPI (marker for enterocytes) and lysozyme (marker for Paneth cells) but an 
increase in the expression of Muc2 (marker for goblet cells) (figure3.8 o-q).  
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Figure 3-8 iDKO mice show delayed recovery abdominal radiation injury. 
CT conformal 14Gy abdominal X-ray radiation treatment was standardized using WT 
mice which quickly recovered from the mucosal damage (a-c). iDKO mice on exposure 
of the same treatment showed significant delay in recovery from the injury as evidenced 
by the weight loss, H&E and Ki67 staining ( d-i). This inability to repopulate injured 
epithelia coincided with precipitous drop in Lgr5-Hi stem cells in iDKO mice (j-n). 
Differentiation to enterocyte and Paneth cell lineages was also reduced but increase in 
Muc2 showed the trend towards goblet cell fate differentiation in iDKO at 5 days after 
TAM (o-q). Experiments shown in figures 3.8 d-i were repeated three times. Flow 
cytometric analysis of stem and progenitor cells was repeated four times (j-n). Real-time 
PCR was performed once (o-q). 
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3.9 Inability of iDKO crypts to self-renew prohibits their re-
passage in organoid assay 
Crypts can be cultured in vitro as organoids in the presence of essential growth factors 
(R-spondin1, EGF and Noggin) and an extracellular matrix material like matrigel (BD 
Bioscience) (49)(222). Organoids can also be generated from single Lgr5+ stem cells, 
albeit at a much reduced frequency (222). Because Lgr5-Cre is mosaic in expression, for 
these experiments we used another mouse model in which both alleles of Cbl and Cbl-b 
are floxed and they have been bred to TAM inducible Cre expressed under the 
ubiquitous Rosa26 promoter (figure3.9a). We started by isolating the crypts from Cblf/f; 
Cbl-bf/f (Control) and from Cblf/f; Cbl-bf/f; R26-CreERT+ (Experimental) mice, and 
embedding them in matrigel with the growth conditions mentioned above. 24 hours after 
plating we observed that the luminal ends of crypts had sealed off and they looked like 
tiny balls (figure3.9b-c). 3 days after plating, the crypts began budding and after 8 days 
they had metamorphosed into organoid structures with well-defined crypt regions, 
connecting villus domains and luminal mass comprising of dying cells (figure3.9d-i). 
After 8 days of initial plating we re-plated these organoids in a split ratio of 1:4 and grew 
them for another 4 days before introducing 4-hydroxy tamoxifen (4-OH TAM) into the 
culture to activate the Cre (figure3.9 j-m). After 24 and 48 hours of TAM treatment, we 
found DKO organoids grew more rapidly but by 72 hours after induction they began to 
deteriorate (figure3.9 j-m). Real-time PCR analysis at 72h time point showed reduction 
in the transcripts of both Cbl and Cbl-b (figure3.9 n-o). When the 4-OH TAM treated 
structures were re-plated for a second passage at a split ratio of 1:4, Control organoids 
re-created the same 3-dimensional (3-D) structure with intact crypt and villus domain but 
not a single organoid could be seen in case of DKO (figure3.9 q-s). This showed that 
combined loss of Cbl/Cbl-b coincided with loss of self-renewal in the organoid structures. 
  
 
99 
Figure 3-9 Loss of CBL proteins reduces the self-renewal potential of iDKO 
organoids. 
 We used Cbl; Cbl-b double floxed mice carrying Cre under ubiquitous Rosa26 promoter. 
For these experiments we cultured Cre negative (Control) and Cre+ (iDKO) mice (a). 
Initial growth kinetics was indistinguishable between both the genotypes (b-i). These 
organoids were re-plated and exposed to 4-OH TAM to induce deletion of Cbl proteins 
(j-m). iDKO mice showed enormous budding of organoids till 48h time point. At 72h after 
TAM induction, DKO organoids lost their 3D morphology. qPCR analysis confirmed 
reduction of Cbl proteins at 72h time point (n-o). Re-passage of iDKO organoids did not 
generate any organoids suggesting a loss of self-renewal (p-s). These experiments were 
repeated two times.   
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3.10 Hyperactive MAPK pathway in Cbl/Cbl-b DKO in organoids 
suppresses Wnt pathway 
Organoids were collected at 24 hour and 72 hour time points after TAM treatment and 
lysed to isolate proteins to study cell signaling changes accompanying the phenotypic 
alterations (figure3.10a-b). Upregulation of p-MEK1/2, p-AKT and p-S6 in the DKO 
organoids at both time points are indicative of hyperactive MAPK pathway. At the same 
time we analyzed TCF4 expression, which is the transcription factor that activates the 
transcription of Wnt target genes and is considered to be indispensable for maintenance 
of stem/progenitor compartment of the intestine (223, 224). In the intestine, the different 
splice variants of Tcf4 have been identified that have different capacity to bind to DNA 
and hence carry out transcription of downstream Wnt effector genes (150, 225). While 
the longer 70 kDa isoform, Tcf4E has a binding site for CtBP (carboxyl terminal binding 
protein) and an elongated C-terminal domain harboring a C-clamp (a DNA binding 
domain), the shorter 50 kDa isoforms, Tcf4M and Tcf4S lack both these structures (150, 
225).  Although the shorter isoforms can bind to Wnt response elements and can be co-
immunoprecipitated with β-catenin, they cannot initiate transcription of target genes such 
as Axin2 (225). Interestingly, MAPK signaling has been shown to regulate the relative 
abundance of these isoforms at the translational level (150). Indeed, we observed that at 
the 24h time point, there was an increase in the 70kDa isoform but by 72 hours it 
decayed drastically. In addition to confirming previous findings of MAPK signaling as a 
regulator of Wnt activity (150), these data also suggest that fine tuning of MAPK 
signaling can have very different effects on Wnt pathway output, thereby regulating 
properties like self-renewal and differentiation. 
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Figure 3-10 Hyperactivation of MAPK signaling reduced functional TCF4 isoform 
expression. 
Probing cell signaling changes at early (24h, a) and late (72h, b) time points showed that 
loss of Cbl proteins was accompanied by increased output through MAPK signaling as 
seen by upregulation of p-AKT, p-Mek1/2 and p-S6. This hyperactivation of MAPK 
signaling appeared to have fine-tuned the translation of different isoforms of TCF4, 
which is the effector of Wnt pathway. This could possibly be responsible for loss of self-
renewal seen in iDKO organoids. 
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4 Discussion  
Multiple biochemical and cell biological studies have established that CBL family of 
proteins (CBL, CBL-B and CBL-C) function as negative regulators of activated receptor 
and non-receptor tyrosine kinases by ubiquitinating and targeting them for degradation. 
While in vivo analysis of these proteins has established them as critical regulators of 
immune function, hematopoietic system and neural progenitors, their function in 
epithelial organs is not clearly established. Detailed analysis of the mammary gland in 
our lab, revealed that CBL and CBL-B, the two full length family members of CBL family, 
are vital to the development of this gland such that in their absence there is reduced 
ductal branching and defects in mammary stem cell self-renewal (Mohapatra et al., 
unpublished). This finding was very counterintuitive considering the role of activated 
protein tyrosine kinases in hyper-proliferative epithelial cancers (141-147, 148-149). In 
order to tease apart the role of CBL proteins in another epithelial organ we decided to 
look at the intestinal epithelium not only because it is the fastest self-renewing tissue in 
mammals, has a well-defined tissue architecture with well characterized 
stem/progenitor/differentiated cell population but also because RTK signaling plays a 
crucial role in its normal physiology and pathology.  
Since no study thus far had looked at the expression or function of CBL proteins in 
the intestinal epithelium, we decided to begin by first studying their expression pattern in 
the tissue. Our analysis using immunohistochemistry, western blotting and quantitative 
real-time PCR revealed that CBL and CBL-B are both expressed in a gradient from crypt 
to villus. Crypt enrichment of these family members pointed to their potential role in 
regulating the proliferative stem/progenitor compartment of intestine that is also localized 
within the crypts (Fig. 3.1). LacZ expression analysis of Cblc LacZ knock-in mice 
revealed a reverse expression pattern to the other two family members. Cbl-c was 
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highest in the villi, which comprise the differentiated cells of the intestinal epithelium (Fig 
3.1). Thus, from our expression analysis as well as from our previous analysis of 
hematopoietic and mammary gland systems we proposed that CBL and  CBL-B might 
play redundant roles in the maintenance of tissue resident stem cells of intestinal 
epithelium. Since Cbl-c expression was mainly restricted to differentiated epithelial cells 
and Cbl-c-/- mice have no apparent phenotype we decided to focus our analysis on Cbl 
and Cbl-b for further studies.  
Next, we decided to look at the gut of single Cbl and Cbl-b knockout mice. We found 
that while Cbl-b-/- mice looked indistinguishable from age matched WT animals, Cbl-/- 
mice showed goblet cell hyperplasia and increased commitment of stem/progenitor cells 
towards cell cycle entry (Fig 3.2). This finding showed that even though CBL and CBL-B 
may regulate certain aspects of tissue maintenance redundantly, some degree of fate 
determination was controlled solely by CBL. Nonetheless, because of their largely 
overlapping expression pattern, we decided to study their function together, in the 
intestinal stem cells. As mentioned before a whole body combined knockout of Cbl and 
Cbl-b is not conducive for live birth, thus, we generated a novel intestinal stem cell 
specific DKO of Cbl and Cbl-b by introducing Cblf/f; Cbl-b-/- alleles in Lgr5-eGFP-IRES-
CreERT2; R26-LSL-LacZ mice (Fig 3.3). This model allowed us to not only monitor self-
renewal based on the GFP expression within the Lgr5+ compartment but also assess 
their ability to commit to differentiated cell fate in an inducible fashion.  
Analysis of proliferation in the iDKO (inducible double knockout) mice revealed 
increased entry into the cell cycle with no change in apoptosis (Fig. 3.4). This phenotype 
was similar to the one observed in Cbl-/- mice, although the difference was more 
significant in iDKO mice. This suggested that even though proliferation within the 
stem/progenitor compartment was predominantly controlled by CBL, there was an 
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additive effect on the phenotype with the loss of both family members. Further scrutiny of 
self-renewal using flow cytometric analysis of GFP+ Lgr5 cells demonstrated a 
significant drop in the percentage of live Lgr5-Hi stem cells with a concomitant increase 
in Lgr5-Lo progenitor cells in the iDKO mice (Fig 3.5). These data combined with the 
previous analysis of proliferation and apoptosis suggested that Lgr5-Hi cells were 
committing to differentiation over self-renewal in the iDKO mice.  
To further probe the differentiation phenotype, we performed lineage tracing 
experiments of iDKO and WT mice by staining for LacZ (Fig 3.6). These data showed 
increased blue staining in the villi as well as crypts of iDKO mice suggestive of increased 
commitment to differentiation. Analysis of crypt filling pattern revealed a significant 
increase in the percentage of partially and fully blue crypts but a precipitous drop in the 
crypts with a single blue cell.  These blue cells represent Lgr5 expressing cells that did 
not divide, and hence comprise the Lgr5 expressing quiescent secretory progenitor 
fraction. It was interesting to note that in the absence of CBL proteins a loss of 
quiescence did not translate into reverting to stem cell fate (as they are known to 
interconvert with Lgr5+ stem cells) instead differentiated into progeny as evidenced by 
the continued depression in the percentage of GFP-Hi cells at the 10d time point. Since 
GFP+ stem cells do eventually equilibrate their numbers when the effect of TAM has 
subsided (Fig. 3.4 o), it could mean that the abundant ALPI expressing proliferative 
absorptive progenitors could potentially be the candidate cells that replace the lost   
Lgr5-Hi stem cells as has been shown recently by Hans Clevers’ group (39).  
Identification of differentiation fates taken by iDKO stem cells, revealed a preference 
towards enterocyte and goblet cell fate (Fig. 3.7) and a loss of Paneth cell compartment. 
Interestingly, it has previously been shown that signaling downstream of RTKs can tilt 
the balance amongst different types of secretory cells (150, 137, 139). Loss of Paneth 
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cells in the iDKO crypts coincided very well with the loss of quiescent secretory 
progenitor population, whose default fate was shown to be Paneth cells (36). However, 
at this point it is difficult to ascertain if loss of Cbl/Cbl-b impacts the allocation of Lgr5+  
quiescent compartment or promotes their conversion to alternate fates (such as goblet 
cells or enterocyte).        
Nonetheless, loss of quiescent progenitors could have deleterious implications for 
maintaining homeostasis of intestinal epithelia especially under circumstances that could 
kill proliferating cells such as exposure to anti-mitotic drugs or exposure to radiation 
injury. To assess the impact of such an injury on the self-renewal of Cbl/Cbl-b deficient 
epithelia we subjected mice to radiation injury (Fig. 3.8). As expected, loss of CBL 
proteins rendered the stem/progenitor compartment incapable of re-establishing 
epithelial homeostasis. One possibility could be that in the absence of a functional 
quiescent compartment and because radiation killed the proliferating ALPI+ enterocyte 
progenitors, the stem cell pool could not be repopulated soon enough to regain epithelial 
integrity.  
A potential limitation of our mouse model was the constitutive knockout of Cbl-b in all 
the cell types of the intestine. As Cbl-b -/- mice have been reported to have a 
hyperactive immune system when challenged with antigens (169, 197, 198), to 
overcome this constraint we made use of our newly generated mouse model carrying 
both Cbl and Cbl-b alleles as floxed with TAM inducible Cre being expressed from the 
R26 promoter to study the effect of loss of CBL proteins in in vitro culture of crypts (Fig. 
3.9). Not only did this model recapitulate the loss of self-renewal phenotype of DKO 
mice, but it also allowed us to assess cell signaling changes that accompanied the said 
phenotype, which was difficult to perform in the mosaic Lgr5-Cre model. In keeping with 
the expected role of CBL proteins as negative regulators of PTK signaling, loss of Cbl 
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proteins increased the downstream effector MAPK signaling through both AKT and MEK 
pathways. This hyperactivation of the MAPK pathway interestingly also accompanied 
changes in TCF4 isoforms confirming the observations of Heuberger et al., 2014 (150) 
who showed that reduction in MAPK signaling through knockout of its positive regulator 
SHP2 caused degradation of the lower defective TCF4 isoform. In contrast, we saw that 
hyperactivation of MAPK signaling through loss of Cbl/Cbl-b stabilized the lower TCF4 
isoforms but reduced the longer functional isoform. Since this longer isoform is 
responsible for activation of Wnt targets, we believe that loss of self-renewal observed 
upon knockout of CBL proteins could possibly be due to the effects of dysregulated 
MAPK signaling on Wnt pathway, which is a well-known preserver of self-renewal in the 
intestine.  
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5 Conclusion    
The work presented within this thesis describes the role of CBL family of proteins as 
essential regulators of epithelial homeostasis under normal physiology and injury 
conditions. Due to their E3 Ubiquitin ligase function, CBL proteins are well known 
negative regulators of activated protein tyrosine kinases. However, their in vivo function 
in the context of epithelial tissues is still not known, even though their targets such as 
EGFR, FGFR and PDGFR play crucial roles during development as well as 
pathogenesis of epithelial tissues. Since the intestinal epithelium is the fastest self-
renewing epithelial tissue, we chose to focus on it to delve into the question of CBL 
proteins’ purpose in the maintenance of this tissue.  
As this was the first work done to decipher the role of CBL proteins in the gut, we first 
determined their expression pattern. We found that while CBL/CBL-B are expressed 
predominantly within the crypts, Cbl-c is restricted to the villi. Germline deletion of Cbl 
led to increased proliferation within the crypts and commitment to goblet cells. We 
further designed a novel mouse genetic model (Cbl-flox/flox; Cbl-b-null; Lgr5-CreERT2-
IRES-EGFP; R26-LacZ) to examine the combined role of CBL and CBL-B in the 
epithelial stem cells of the intestinal epithelium. Tamoxifen injection in this inducible 
CBL/CBL-B double knockout (iDKO) mouse model resulted in a rapid and significant 
reduction in the Lgr5-High intestinal epithelial stem cell (IESC) pool with a concomitant 
increase in the Lgr5-Lo transit amplifying cells. Lineage tracing using LacZ-staining 
revealed an increase in the number of blue progeny in the iDKOs, suggesting an 
increased IESC commitment to differentiation. Of the progeny, iDKO animals showed a 
propensity towards enterocyte and goblet cell fate at the expense of Paneth cells. Loss 
of IESCs in iDKO mice led to slower recovery from intestinal epithelial injury due to X-ray 
radiation of the abdomen. In vitro culture of crypts of Cblf/f; Cblbf/f; R26CreERT mice 
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reiterated the loss of self-renewal phenotype seen in the iDKO mice. Analysis of cell 
signaling revealed hyperactivation of MAPK pathways which was accompanied by 
changes in the relative abundance of TCF4 variants.  These results demonstrate a novel 
requirement of Cbl/Cbl-b in the maintenance of a well-studied epithelial stem cell 
compartment, the IESC, and suggest that CBL proteins by regulating MAPK signaling to 
protect IESCs from exhaustion by balancing commitment to differentiation vs. self-
renewal.  
Thus, our study showcases this novel role of Cbl proteins as regulators of stem cell 
fate in the intestinal epithelium. These results could have possible implications in the 
field of regenerative medicine as well as cancer. For example, inhibition of CBL proteins 
using small molecule inhibitors could result in pro- as well as anti-proliferative effects 
depending on the dose and extent of inhibition.  
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6 Future Directions 
Our study has for the first time elucidated the expression and function of CBL and CBL-B 
proteins in the context intestinal epithelium. However, there have been some limitations 
of our model system as well as some questions that remain unanswered.  
To study the combined role of redundantly functioning CBL/CBL-B we crossed floxed 
Cbl with Cbl-b-/- mice to obtain a DKO in the intestinal stem cells using Lgr5-Cre. 
However, Cbl-b-/- mice have a hyperactive immune phenotype when challenged with an 
allergen. Although in the context of normal homeostasis, Cbl-b-/- intestinal epithelium did 
not show a phenotype but a much more detailed investigation is required especially in 
case of radiation or other kinds of epithelial injury (such as dextran sodium sulfate 
induced colitis) which are thought to instigate immune cells. To overcome this challenge 
to some extent and study purely epithelial contributions of CBL-B, we used Cblf/f;      
Cbl-bf/f crypts in vitro to corroborate the in vivo findings. Nonetheless, combining the 
floxed alleles with an intestinal epithelium specific Cre that deletes in a less mosaic 
fashion such as Villin-CreERT could further confirm our findings.  
Secondly, the effects of intraperitoneal TAM injection induced deletion in our model 
system were transient and stem cells are able to re-establish their numbers at a later 
time point examined due to extensive plasticity within the crypt cells. A long term effect 
of abolishing CBL proteins could, thus, not be assessed. An alternative to this drawback 
could be a continuous pulse of TAM given in chow. However, effectiveness of this 
strategy to induce deletion of CBL proteins would need to be assessed. If this strategy 
would be effective in knocking out CBL for an extended period of time, it would be 
interesting to see if complete exhaustion of stem cells under these circumstances would 
be incompatible with life or would neighboring Cre negative crypts undergo increased 
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rates of fission to generate the epithelium that would potentially have no GFP positive 
crypts.  
Part of the reason for the reduced ability of iDKO epithelium to recover from radiation 
damage could have been the loss of quiescent Lgr5+ progenitor pool. From the 
literature, these cells under normal homeostasis have been shown to be precursors of 
Paneth cells and under injury conditions have been demonstrated to de-differentiate into 
Lgr5+ stem cells to re-establish recovery of the epithelial lining. Thus, the effects seen in 
iDKO mice with respect to reduced Paneth cells and delayed recovery from injury could 
be ascribed to the loss of quiescent Lgr5+ fraction. However, to look at the role of CBL 
proteins more directly within the quiescent progenitors, it would be interesting to directly 
delete CBL proteins in this compartments using DLL1 or Ngn3 directed Cre. If CBL 
proteins are indeed essential for maintenance of quiescence, it could have therapeutic 
implications in case of cancer where relapse has been associated with dormant clones 
of cancer stem cell population.  
Since CBL and CBL-B in this study have been shown to maintain self-renewal within 
the normal intestinal stem cell compartment, it would be of immediate interest to see if 
this finding translates to cancer stem cells since they are thought to be derivatives of 
normal stem/ progenitor compartment (58, 159-165). However, because of increased 
ability of CBL-B-/- mice to reject spontaneous tumors (203), it would be necessary to use 
Cbl-bf/f alleles along with floxed Cbl alleles in these experiments. Because loss of CBL 
proteins accompanies hyperactivation of MAPK signaling and downregulation of Wnt 
pathway activator TCF4, it would be interesting to see the effect of their absence on the 
tumorogenic potential in both Wnt hyperactivation cancer model of Apc and MAPK 
hyperactivation model of KrasG12D  mutations. An easier approach would be to stably 
transfect colon cancer cell lines with inducible shRNAs against Cbl and Cbl-b and 
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perform subcutaneous transplants in immune compromised mice and monitor tumor 
development.  
Heuberger et al., showed that downregulation of MAPK signaling resulted in 
hyperactivation of Wnt pathway in the intestine and that this regulation was proteosome 
mediated (150). Our data showed that the converse of this regulation was also true, i.e., 
hyperactivation of MAPK by knockout of Cbl and Cbl-b resulted in downregulation 
functional TCF4 isoform. Although TCF4 is the main TCF/LEF family member in the 
adult intestinal epithelium, it will be imperative to also assess the transcription of its 
target genes in iDKO animals as well as in iDKO organoids.  
Lastly, the exact mechanism of interaction between MAPK and Wnt pathway would 
be important to tease apart especially since it has been reported in the endothelial cell 
system that CBL proteins degrade nuclear β-catenin, thereby downregulating Wnt 
pathway (227). It could be possible that such a regulation may not take place in the 
epithelial cells. On the other hand, β-catenin can interact with both the isoforms of TCF4, 
hence it could be possible that in the epithelial cells CBL proteins’ could preferentially be 
targeting the β-catenin pool complexed with shorter isoforms? Or the interaction of CBL 
and TCF4 could be independent of β-catenin. Nonetheless, it would be important to 
understand the nature of interaction between the two pathways. 
Overall, using novel genetic mouse models we have demonstrate that by regulating 
MAPK signaling CBL/CBL-B maintain IESCs, balancing commitment to differentiation vs. 
self-renewal and hence preventing exhaustion of stem cells.  
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